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Abstract
The purpose of the present study is to identify psychological factors that predict a longer
length of stay (LOS) and minimal improvement in a headache inpatient unit. Research
shows that some psychological factors associated with headache disorders, such as
anxiety, depression, and maladaptive coping skills, can complicate the disorder. The
present study theorized that psychological factors that complicate the headache disorder
would predict a longer LOS and minimal improvement. The present study used a quasiexperimental, prospective, cross-sectional survey research design, with multiple
regression analyses. There was a total of 51 completed protocols. Of those completed
protocols, 78% of participants were age 35 years and older. Of consenting participants,
82% were Caucasian women. Results indicated that the hypothesized model to predict
LOS and minimal improvement was not significant. Paired-samples t-test analyses
indicated that there were significant reductions of BPI-SF interference and severity scores
after inpatient treatment, presenting a basis for further research involving comparison
groups.
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Chapter One: Introduction
Statement of the Problem
Headache for most people, although a nuisance, is usually infrequent and
resolvable. However, for a proportion of the population, headache is a chronic disorder
that is disabling, significantly impeding quality of life (Lipton & Newman, 2003).
According to Jensen and Stovner (2008), “the scope and scale of the burden of headache
is underestimated, and headache disorders are universally under-recognized and
undertreated” (p. 354). Globally, of the adult population, 47% have a general headache
condition, 10% have a migraine disorder, 38% have Tension-Type Headache, and 3%
have a chronic headache disorder (Jensen & Stovner, 2008). Disability from TensionType Headache is greater than that from migraine because of its higher prevalence,
despite migraine being considered the ninth most costly neurological condition for both
genders, and the third most costly for women (Jensen & Stovner, 2008). Headache is one
of the 10 most disabling disorders for both genders, and the fifth most disabling for
women (Jensen & Stovner, 2008).
Prevalence rates for debilitating headache disorders vary depending on
demographic characteristics, such as age, region of the world, and gender (Diamond et
al., 2007). A study conducted from 1992 to 2001 found that visits for headaches in
emergency departments occurred with average rates of 10.9 for women, versus 4.6 for
men, per 1,000 persons in the United States population (Goldstein, Camargo, Pelletier, &
Edlow, 2006). In terms of race, Goldstein et al. (2006) found that the rate was 7.5 for
Caucasian patients, 12.0 for African American patients, and 2.2 for other races. The rate
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for Hispanic patients was 4.6, while the rate for nonHispanic patients was 6.5. They also
found that emergency department visits for headaches were most common for patients in
the age range of 18 - 49 years. According to Freitag, Lake, Lipton, and Cady (2004),
African American men and women have prevalence rates for Chronic Tension-Type
Headache, Chronic Migraine, and Frequent Headache of Other Types that are lower than
those for Caucasian men and women. In regards to region, Migraine is more prevalent in
Europe (14.8%) and North America (11.1%) than it is in Africa (4%) (Jensen & Stovner,
2008). Tension-Type Headache is more prevalent in Europe (80%) than it is in Asia and
the Americas (20 - 30%). Chronic headache is most common in Central and South
America (5%) and least common in Africa (1.7%). According to Jensen and Stovner
(2008), the male to female ratio for Migraine varies from 1:2 to 1:3, with women having
more Migraine without Aura than Migraine with Aura. For Tension-Type Headache,
women are only slightly more affected, with a ratio of 4:5. Interestingly, there is no
gender difference in incidence for prepubertal children. In terms of age, Tension-Type
Headache peaks between the ages of 30 and 39 years, for both genders. Onset of migraine
occurs in the 20’s and 30’s; it peaks in the 40’s and declines thereafter. Chronic headache
disorders span a lifetime, increasing until the 50’s, with only a minor decline with age.
In addition to physical pain and suffering, patients suffer economic, occupational,
and social losses (Krymchantowski, Adriano, De Góes, Moreira, & Da Cunha Jevoux,
2007). The second American Migraine Study conducted in 1999 found that only 9% of
participants were able to work or function normally with their headache condition (Lipton
& Newman, 2003). Likewise, 59% of participants reported that they missed family
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functions or social leisure activities. Stovner and Hagen (2006) found that headache
presents more of a burden for patients than do disorders such as Epilepsy, Multiple
Sclerosis, and Parkinson’s disease, as measured by the Disability-Adjusted Life-Years.
Yet, despite the burden of migraine, there are still many underdiagnosed cases that do not
receive appropriate treatment (Diamond et al., 2007).
Aside from the impact headaches have on patients’ lives, they also create
significant direct and indirect costs for society, as reviewed in the study by Munakata et
al., (2009). The most recent American Migraine Prevalence and Prevention Study, a fiveyear longitudinal study, evaluated the impact of migraine on utilization of health-care
resources and on productivity loss (Munakata et al., 2009). Data from the first 2 years of
the study showed that participants with transformed migraine reported more primary-care
visits, neurology and headache-specialist visits, emergency-room visits, and pain clinic
visits as compared to participants with episodic migraine. In terms of productivity,
participants with transformed migraine reported significantly more time missed from
work or school because of headaches. Participants with transformed migraine also
reported more time at work or school when productivity was reduced by half because of
headaches. Participants with transformed migraine incurred significantly more direct and
indirect costs ($7,750 per patient, per year) as compared to participants with episodic
migraine ($1,757 per patient, per year). Lost productivity accounted for 55.7% of the
costs for participants with migraine and 69.6% of the costs for participants with
transformed migraine. Specifically, with indirect costs resulting from absenteeism,
participants with migraine lost 13.7 hours per person, per year, while participants with
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transformed migraine lost 85.7 hours per person, per year. With indirect costs caused by
reduced productivity, participants with migraine lost 48.3 hours per person, per year,
while participants with transformed migraine lost 256 hours per person, per year.
To reduce costs from headache, patients must be treated by appropriate
professionals in appropriate settings (Saper, Silberstein, Gordon, Hamel, & Swidan,
1999). Inpatient treatment for patients with headache is sometimes a warranted and
necessary evil, that is, “the severity of the illness must match the intensity of the service”
(Saper et al., 1999, p.13). According to Saper et al. (1999), when hospitalization is
appropriate to patients’ conditions, it can reduce both direct and indirect costs. For
example, successful hospitalizations can lead to longer periods of headache-free time and
consequently less frequent medical care, thus reducing associated direct costs. Likewise,
more headache free time results in less frequent work absences, thus reducing indirect
costs. On the other hand, if hospitalization is not appropriate, or if there is an
unsuccessful outcome, both direct and indirect costs increase. Examining factors
associated with a longer length of stay (LOS) and minimal improvement potentially can
provide an efficient way to identify patients who need more support before or during
hospitalization in order to prevent and/or remediate factors that impede success of
inpatient treatment.
The relationship between LOS and treatment outcome for inpatients with
headache is an important area of study, not only because of the limited research on the
topic but also because of the potential to reduce costs associated with headaches.
Likewise, few studies have found treatment parameters that predict success for inpatient
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treatment (Grazzi et al., 2002). Identifying factors associated with a longer LOS and
minimal improvement can lead to the development of a rubric for teams who treat
inpatients with headache that can help them to better decide specialized care for
refractory cases in order to promote a timely, successful hospitalization.
Purpose of the Study
Research focused on factors associated with minimal improvement has not been
clear about the way factors interact to predict a poorer outcome or about the stipulations
of individual differences that may preclude predictive value for certain individuals.
According to Grazzi et al. (2002), “multiple factors interact in varied ways to determine a
patient’s response to treatment” (p. 7). The purpose of the present study is to determine
whether a combination of psychological variables predicts a longer LOS and minimal
improvement for inpatients with headache, in order to create a rubric that directs
specialized care for refractory cases. The study will analyze the significance of potential
predictors in determining a longer LOS and minimal improvement. This author proposed
that psychological factors that complicate the headache disorder will be associated with a
longer LOS and minimal improvement.
Overview of Literature Review
Owing to the dearth of research on psychological factors that predict inpatient
treatment outcome and LOS, the literature review focuses primarily on psychological and
demographic factors that complicate headache disorders, and may lead to a poorer
treatment outcome. The literature review describes headache classifications and the
medical and psychological pathologies of and treatments for headaches. Research on the
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relationships among pain and psychological and demographic factors will be presented.
Likewise, the biopsychosocial model and stress diathesis model will be presented to
review the connection between biology and psychology in the pathology of medical
conditions.
Relevance to the Broad and General Knowledge Base of Psychology
The present study emphasizes the goal to expand the value of psychology to other
disciplines, specifically the medical field. This study aims to incorporate the use of
psychological measures in hospital settings in order for the field of psychology to define
and expand further its role in the medical field. This study emphasizes the need for
medical and mental-health professionals to collaborate to discuss the ways medical and
psychological factors interact to result in minimal treatment outcome.
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Chapter Two: Literature Review
Headache Disorders
Headache is a complex disorder with various etiological contributors, both genetic
and environmental (International Headache Society, IHS; 2004). The lack of a single
clear-cut headache etiology caused frustration for patients. There are many variations of
headache disorders, likely caused by the numerous potential combinations of etiological
contributors. As is applicable to this study, headache diagnoses will be reviewed to reveal
their impact on quality of life.
According to the International Classification of Headache Disorders, 2nd edition,
the first step in diagnosing headache is to determine whether the headache is a primary or
secondary disorder (IHS, 2004). Primary refers to headaches that are not caused by
another disorder known to produce headaches. Secondary refers to headaches that are
caused by another disorder. Both primary and secondary diagnoses can be given
simultaneously (IHS, 2004). Basic primary headache categories, such as migraine and
tension-type, will be reviewed. Secondary headaches, such as Medication Overuse
Headache, will be discussed also, as they frequently appear in inpatient settings (Saper,
2008).
Migraine is divided into two main categories, Migraine with Aura and Migraine
without Aura (IHS, 2004). To meet diagnostic criteria for Migraine without Aura, an
individual must have at least five attacks lasting between 4-72 hours per month (untreated
or unsuccessfully treated). Headache pain also must meet two of the following
characteristics: unilateral, pulsating, moderate to severe intensity, and/or aggravated by
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physical activity. Additionally, during a headache, an individual must have at least one of
the following symptoms: nausea and/or vomiting or photophobia and/or phonophobia
(sensitivity to light and sound, respectively).
Migraine with Aura is characterized by focal neurological symptoms that precede
and/or accompany the headache (IHS, 2004). To meet diagnostic criteria, an individual
must have at least two attacks per month with no motor weakness and at least one of the
following symptoms: fully reversible visual homonymous symptoms, including flickering
lights, spots, lines, loss of vision; fully reversible unilateral sensory symptoms, including
pins and needle, numbness; and/or a fully reversible dysphasic speech disturbance. At
least one aura symptom must develop in 5 minutes or less, and/or aura symptoms must
occur in succession for at least 5 minutes. Each aura symptom must last for at least 5
minutes.
There are diagnoses to account for disorders that are similar to Migraine with
Aura and Migraine without Aura (IHS, 2004). Typical Migraine With Aura is diagnosed
when there is aura with a headache meeting the criteria for Migraine without Aura.
Typical Nonmigraine Headache with Aura is diagnosed when typical visual, sensory,
and/or auditory aura symptoms occur without a headache characterized by the criteria of
Migraine without Aura.
Differentiations of migraine include diagnoses such as Familial Hemiplegic
Migraine, Sporadic Hemiplegic Migraine, Basilar-Type Migraine, and Retinal Migraine
(IHS, 2004). Familial Hemiplegic Migraine is diagnosed if the aura associated with
Typical Migraine with Aura includes motor weakness, and at least one first- or second-
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degree relative has migraine aura with motor weakness. Sporadic Hemiplegic Migraine is
diagnosed when there is motor weakness without a familial link. Basilar-Type Migraine
is distinguished from other migraine disorders by its simultaneous effect on both
hemispheres. Basilar-Type Migraine is diagnosed when at least two attacks per month
occur with aura, without motor weakness, and with two of the following symptoms:
dysarthria (difficulty articulating words), vertigo, tinnitus, hypacusia (hearing
impairment), diplopia (double vision), visual symptoms in both temporal and nasal fields
of both eyes, ataxia, decreased level of consciousness, and/or simultaneous bilateral
paraesthesias. Retinal Migraine is characterized by reversible monocular visual
disturbance, such as scintillations (flashing or sparkling), scotomata, and/or blindness.
Complications also can occur with migraine disorders that warrant additional
diagnoses, such as Chronic Migraine, Persistent Aura without Infarction, Migrainous
Infarction, Status Migrainosus, and Migraine-Triggered Seizure (IHS, 2004). Chronic
Migraine is diagnosed when a migraine headache occurs on 15 or more days per month
for more than 3 months in the absence of medication overuse. Persistent Aura without
Infarction is diagnosed when one or more of the aura symptoms typical of a previous
Migraine with Aura attack lasts for more than a week without evidence of an infarction.
Migrainous Infarction is diagnosed when one or more migrainous aura symptoms are
associated with an ischaemic brain lesion. Status Migrainosus is diagnosed when a severe
migraine typical of Migraine without Aura lasts more than 72 hours. Migraine-Triggered
Seizure is diagnosed when a migraine aura typical of Migraine with Aura triggers a
seizure.
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Tension-Type Headache is divided into the following categories: Infrequent
Episodic Tension-Type Headache, Frequent Episodic Tension-Type Headache, Chronic
Tension-Type Headache, and Probable Tension-Type Headache (IHS, 2004). Infrequent
Episodic Tension-Type Headache is diagnosed when two of the following characteristics
are met: bilateral location, pressing or tightening quality that is nonpulsating, mild or
moderate intensity, and/or not aggravated by routine physical activity. While there may
be anorexia, there is no nausea or vomiting, and there is not more than one symptom of
photophobia or phonophobia. Headaches must last at least 30 minutes and can last up to 7
days. At least 10 episodes must occur, but no more than once a month and 12 days per
year. Frequent Episodic Tension-Type Headache has the same criteria as Infrequent
Episodic Tension-Type Headache except that headaches occur more than once a month
but fewer than 15 days per month, for at least 3 months.
Chronic Tension-Type Headache, also labeled as New Daily-Persistent Headache,
is diagnosed after 3 days of unambiguous symptoms similar to Frequent Episodic
Tension-Type Headache symptoms that last for hours or are continuous (IHS, 2004).
Probable diagnoses for infrequent and frequent episodic headaches (Probable Infrequent
Episodic Tension-Type Headache and Probable Frequent Episodic Tension-Type
Headache) are given when patients meet all but one criterion. Probable Chronic TensionType Headache is diagnosed when all criteria are met for Chronic Tension-Type
Headache, and within the past 2 months some form of Medication-Overuse Headache is
present.
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Medication-Overuse Headache is divided into several categories: ErgotamineOveruse Headache, Analgesic-Overuse Headache, Triptan-Overuse Headache, OpioidOveruse Headache, and Combination Medication-Overuse Headache (IHS, 2004).
Ergotamine-Overuse Headache is diagnosed when a headache is present for more than 15
days per month with at least one of the following characteristics: bilateral,
pressing/tightening (nonpulsating) quality and/or mild or moderate in intensity (IHS,
2004). Likewise, the headache must have developed or worsened as a result of
ergotamine overuse. Headache also must resolve or revert to its usual pattern within 2
months after stopping the ergotamine. Analgesic-Overuse Headache follows the same
diagnostic criteria as Ergotamine-Overuse Headache. Triptan-Overuse Headache is
diagnosed when a headache is present on more than 15 days per month and meets at least
one of the following characteristics: predominantly unilateral, pulsating quality; moderate
or severe intensity; and/or aggravated by or causing avoidance of routine physical activity
(IHS, 2004). Headache also must be associated with at least one of the following
symptoms: nausea, vomiting, photophobia, or phonophobia. Additionally, headache
frequency must have increased during triptan overuse. Headache also must revert to its
usual pattern within 2 months after stopping the triptan.
Opioid-Overuse Headache is diagnosed when headache is present for more than
15 days per month and is associated with development of headache or worsening of
headache during opioid overuse (IHS, 2004). Likewise, headache must resolve or revert
to its usual pattern after 2 months of stopping opioids. Combination Medication-Overuse
Headache is diagnosed when headache is present for fewer than 15 days per month and
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meets at least one of the following characteristics: bilateral, pressing/tightening
(nonpulsating) quality, or mild or moderate intensity (IHS, 2004). Headache also must
develop or worsen during combination-medication overuse and resolve or revert to its
usual pattern within 2 months after stopping combination medications.
There are several reasons for the development of Medication-Overuse Headache.
Patients may overuse medication for pain relief and to function with daily responsibilities
because of inadequate control from medical care (Saper, 2008). Patients with headache
commonly overuse medication to function, rather than to escape from problems or to get
a high (Primavera & Kaiser, 1993; Saper, 2008). Patients with headache may also
overuse because of a low pain tolerance, a fear of pain, and/or a belief of entitlement to
be pain free (Saper, 2008). Medication-Overuse Headache is less likely in patients with
Chronic Tension-Type Headache. However, Episodic Tension-Type Headache in patients
who overuse medications can transform easily to a chronic headache disorder (IHS,
2004). Patients who overuse acute medications rarely respond to preventative
medications.
Headache Pathology
Medical
The pathology of pain in general involves tissue damage, injury, or inappropriate
activation of the pain-producing pathways of the central nervous system (CNS) or the
peripheral nervous system (PNS; Goadsby & Raskin, 2008). Tissue damage stimulates
peripheral nociceptors (pain reception), which is a normal response of a healthy nervous
system (Goadsby & Raskin, 2008).
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While the key structures involved in headache are known, the pathology is more
obscure (Goadsby & Raskin, 2008). The trigeminovascular system, the large intracranial
vessels, dura mater, and the trigeminal nerve that innervates them, is involved in
headache. The caudal portion of the trigeminal nucleus and the pain modulatory systems
in the brain that receive input from the trigeminal nociceptors also are involved in
headache (Goadsby & Raskin, 2008). Several accepted etiological models for migraine
include explanations of multimechanisms, genetic mutations, cortical spreading
depression (CSD), and neurotransmitters (Barbas & Schuyler, 2006). The pathology of
Tension-Type Headache is more obscure (Edmeads, 1998). There are few known
contributing factors to Tension-Type Headache (Barbas & Schuyler, 2006).
Migraine is no longer conceptualized as simply a vascular condition resulting
from blood vessel dilation (Thomas Jefferson University, n.d.). Multiple mechanisms
contribute to the onset of migraine. Specifically, a chain of events, beginning with
inflammation, leads to norciception, vasodilation, and central and peripheral
sensitization. Inflammation involving hormone-like prostaglandins and neuropeptides
results in vasodilation—the widening of the blood vessels. Vasodilation activates
norciception, which transmits pain signals to the thalamus and cerebral cortex, the
location of the first sensation of pain. Activation of the nociceptors leads to increased
stimulation of the nerve cells in the trigeminal nerve (the main sensory nerve). Prolonged
stimulation of the trigeminal nerve results in central sensitization. The multimechanism
explanation accounts for migraine symptoms, such as sensitivity to light and noise and/or
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nausea and vomiting. For example, stimulation of the trigeminal nerve may affect any of
the nerve’s three branches, resulting in sinus, facial, and/or neck pain.
Even when genetics do not appear to play a role in migraine, they are implicated
(Barbas & Schuyler, 2006). In addition to the increased prevalence of migraine among
family members, five susceptible gene locations on four chromosomes have been found
to be linked significantly to Migraine with Aura and Migraine without Aura. Likewise,
Familial Hemiplegic Migraine may provide insight on whether there is a shared cellular
pathogenesis between the Familial Hemiplegic Migraine, more common migraine
subtypes, and other headache conditions (Barbas & Schuyler, 2006; Sanchez-del-Rio,
Reuter, & Moskowitz, 2006). However, there is no single gene responsible for Migraine
with Aura and Migraine without Aura (Barbas & Schuyler, 2006).
According to Sanchez-del-Rio et al., (2006), genetic mutations lead to migraine
aura through CSD. CSD starts with cortical stimulation, followed by a slow wave of
neuronal depolarization that travels across the cortex, resulting in a long-lasting
suppression of neuronal activity. The Familial Hemiplegic Migraine mutations make the
brain more susceptible to CSD through excessive synaptic glutamate release, decreased
removal of glutamate and potassium from the synaptic cleft, or persistent sodium influx.
CSD can be induced experimentally by trauma to the cortex, high extracellular
concentrations of glutamate or potassium, inhibition of NA+/ K+ -ATPase, and other
stimuli. Overall, migraine develops from environmental and genetic causes that enhance
susceptibility to hyperactivity in the cortex, resulting in CSD. However, the complete
picture of the initiation of migraine is still a mystery.
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Neurotransmitters, such as serotonin, are implicated in migraines (Hamel, 2007).
While most studies have not supported a genetic role in serotonin synthesis, there is
strong support for a link between low brain serotonin neurotransmission and migraine
headache (Hamel, 2007). A disposition for low serotonin levels facilitates CSD-induced
trigeminal nociception (Hamel, 2007). Similar to migraine, depression is also a disorder
of low serotonin. Therefore, the comorbidity between depression and migraine is not
surprising (Cahill & Murphy, 2004). However, one family study did not find a genetic
basis for the association between migraine and depression (Cahill & Murphy, 2004).
Twin studies, when conducted, may prove otherwise. As of now, there is no conclusive
evidence for a common genetic etiology for both disorders (Cahill & Murphy, 2004). The
neurobiological relationship between headaches and psychological factors will be
discussed in more detail in the cognitive/affective and biological components section.
While the etiology of Tension-Type Headache is more obscure, several known
psychological, environmental, and neurological factors are linked to Tension-Type
Headache (Bendtsen & Jensen, 2006; Edmeads, 1998). Neurologically, pericranial
myofascial pain sensitivity, which is common in patients with Tension-Type Headache,
could be a result of peripheral sensitization of myofascial nociceptors (Bendtsen &
Jensen, 2006). Studies also suggest that with Chronic Tension-Type Headache, the
central nervous system is sensitized at both the spinal dorsal horn/trigeminal nucleus and
supraspinally (Bendtsen & Jensen, 2006). However, central pain processing seems to be
normal in patients with Episodic Tension-Type Headache (Bendtsen & Jensen, 2006).
Stress and fatigue are known to aggravate Tension-Type Headache, and depression is
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also a common factor (Edmeads, 1998). Epidemiological and twin studies found no
evidence of a strong genetic susceptibility for Tension-Type Headache (Barbas &
Schuyler, 2006).
Psychological/environmental mechanisms
Biopsychosocial model. The model for understanding headaches has progressed
past the biomedical model to the biopsychosocial model (Nicholson, Houle, Rhudy, &
Norton, 2007). The main theme of the biopsychosocial model is the interplay among
biological, psychological, and social processes. Each factor has a unique influence on
headaches; not one is more or less important than the others (Nicholson et al., 2007).
Psychological factors, such as depression, anxiety, coping skills, stress, neuroticism,
catastrophizing, locus of control, self-efficacy, emotional inhibition, and negative
emotions, can play a role in the development, course, and outcome of headaches
(Nicholson et al., 2007). Overall, research shows that psychological problems have an
important influence on the suffering patients with pain (Dersh, Polatin, & Gatchel, 2002;
Korff & Simon, 1996). For example, studies show that psychological factors can trigger
headache potentiation, pain perception, disability, and treatment outcome (Korff &
Simon, 1996; Nicholson et al., 2007).
Biopsychosocial theories categorize the concept of pain into four dimensions:
nociception, pain, suffering, and pain behavior (Gatchel, 2004). Nociception occurs when
nerves send messages conveying tissue damage to the brain. Pain is a subjective
experience that involves the transduction, transmission, and modulation of sensory input.
Sensory input may be filtered through genetic composition, learning history,
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psychological status, and sociocultural influences. Suffering is defined as an emotional
reaction to nociception or an aversive event associated with nociception. Pain behavior is
defined as the reactions people have when they are suffering or in pain, such as avoiding
activities.
Gatchel proposed a biopsychosocial interactive theory of health and illness
(Gatchel, 2004). It proposes that affective, cognitive, biological, and somatic processes
influence the autonomic, endocrine, and immune systems through afferent and efferent
feedback. Underlying all these processes are genetic predispositions. The interactive
processes can influence activities of daily living, environmental stressors, interpersonal
relationships, family environment, social support/isolation, social expectations, cultural
factors, insurance issues, previous treatment experiences, and work history, all of which
also can influence psychological and biological factors.
Gatchel developed a biopsychosocial theory to explain the progression of acute
pain to chronic pain (Dersh et al., 2002). He proposed three stages: normal emotional
reactions, a wider range of psychological problems, and habituation to or acceptance of
some aspects of the sick role. The first stage is characterized by normal emotional
reactions to pain, such as anxiety, fear, and worry. During the second stage, after 2 to 4
months of persistent pain, emotional reactions can persist into psychological problems,
such as learned helplessness, anger, distress, and somatization. According to the stress
diathesis model, psychological problems that develop in the context of pain depend on an
individual’s preexisting psychological and personality characteristics, socioeconomic
factors, and other environmental conditions. The stress of coping with chronic pain
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exacerbates the individual’s preexisting characteristics. During the third stage,
psychological problems persist to the point where the individual’s life revolves around
pain as a result of chronicity. During this stage, patients can habituate to some aspects of
the sick role. They may use the chronic condition as an excuse to avoid responsibility and
social obligations, which could become a reinforcer for maintaining the chronic
condition.
Stress diathesis model. The stress diathesis model is a component of the broader
biopsychosocial model (Korszun, 2002). It is a widely accepted model for stress-related
disorders (Korszun, 2002). The model proposes that stress interacts with underlying
predispositions, thereby causing disorders. Stress can include physical stress, such as a
virus or injury, or psychological stress, such as an event that threatens an individual’s
homoeostasis (Korszun, 2002). For example, an individual who develops a chronic pain
condition may have predispositions, such as negative schemas or deficits in instrumental
skills (Dersh et al., 2002). The stress of chronic pain then may activate the
predispositions, resulting in depression (Dersh et al., 2002).
The stress diathesis model can specify how stress aggravates and/or contributes to
the development of a headache disorder (Nash & Thebarge, 2006). For example, a
preexisting acquired or inherited vulnerability to developing a headache disorder, when
aggravated by stress, can develop into a headache disorder. Electrophysiological studies
suggest stress sensitivity may be a contributor to migraine disorders. Individuals with
migraine have higher levels of cortical arousal between migraine episodes with a lack of
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habituation. Stress sensitivity may develop from the headache disorder, or it may be a
correlate of shared pathophysiology (i.e., serotonin dysfunction).
Link between cognitive/affective and biological components. Studies show that
neural circuits of both headache and cognitive-affective activity are highly intertwined
(Nicholson et al., 2007). The pain circuit comprises the periaqueductal gray, serotonin (5HT) neurons of the rostral ventromedial medulla, and norepinephrine of the dorsolateral
pontomesenchephalic tegmentum (Nicholson et al., 2007). Serotonin is involved in pain
and cognitive-affective activity in a few important ways: production of emotional pain
reactions; obsessive rumination; sleep/awake cycles; long-term, low-level pain
transmission; and regulation of neurotransmitters responsible for alertness (Buelow,
Herbert, & Buelow, 2000). Norepinephrine is involved in maintaining wakefulness and
alertness and the fight-or-flight response (Buelow et al., 2000). Norepinephrine also has
an analgesic effect on pain by slowing the release of substance P (Buelow et al., 2000).
Likewise, some of the pain-relieving effects of opioid analgesics, serotonin agonists, and
norepinephrine agonists occur through the pain circuit (Buelow et al., 2000).
According to Nicholson et al. (2007), pain involves multiple brain regions, which
are also the same regions involved in emotion, attention, and stress, among other
psychological phenomena. Specifically, the amygdala area of the limbic system can
activate the pain circuit, and it is also an important area for emotion. The anterior
cingulated cortex, orbitofrontal cortex, insula, and hippocampus are implicated in pain
modulation through attention, placebo, expectation, perceptions of control, and anxiety.
The interaction between psychological and biological systems may explain the influence

LOS AND INPATIENT HEADACHE UNIT

20

of long-term changes through neuroplasticity and sensitization on the development of
headache chronification and comorbid mood disorders.
Delgado (2006) reported that dysfunction in ascending and descending pathways
of the serotonergic and noradrenergic systems can result in depression and chronic pain.
When the serotonergic and noradrenergic pathways are not working properly, heightened
sensitivity to pain and pain from normally nonpainful stimuli can occur. Antidepressant
medications that act on the serotonergic and/or noradrenergic systems not only improve
mood but also treat symptoms of chronic pain.
According to Cahill and Murphy (2004), the serotonin dysfunction involved in
migraine and depression represents an underactive serotonergic system. Serotonin is
proposed to be involved in migraine as evidenced by changes in serotonin and its
metabolites during migraine attacks, the ability of serotonin to trigger migraine attacks,
and the implication of serotonin in treatment (Cahill & Murphy, 2004). To date, seven
serotonin receptors have been identified: 5-HT1 through 5-HT7 (Sheftell & Atlas, 2002).
Evidence suggests that 5-HT1 is involved in migraines, since effective triptan
medications are 5-HT1 agonists (Sheftell & Atlas, 2002). Serotonin also has been
implicated in anxiety disorders, eating disorders, obsessive-compulsive disorder, (OCD),
and Tension-Type Headache (Sheftell & Atlas, 2002).
Theories propose that psychological factors modulate pain through shared circuits
(Nicholson et al., 2007). Negative affect may influence headaches by activating a
defensive system that creates neural and physiological changes triggering or exacerbating
a headache. Nicholson et al. (2007) defined negative affect as including emotions, such as

LOS AND INPATIENT HEADACHE UNIT

21

anxiety, dysphoria (transient feelings of depression), and anger. Serotonin and gammaaminobutyric acid (GABA) have been implicated as a link in the neurochemistry between
negative affect and headaches. Anxiety is linked to GABA dysregulation.
Correspondingly, some preventative migraine medications reduce cortical excitability by
enhancing GABA-ergic function. At a peripheral level, negative affect can lead to
adrenaline release, sugar infused in the bloodstream, change in blood lipid levels, and
increases in heart rate, respiration, and muscle tension, any of which alone or in
combination can instigate a headache.
The neurotransmitter dopamine also has been implicated in migraine (Sheftell &
Atlas, 2002). Dopamine plays a role in mood, cognition, aggression, pleasure seeking,
motivation, impulse control, substance abuse, and aggression. Likewise, migraine
prodrome symptoms, such as yawning, mood changes, nausea, and vomiting, are treated
with antidopaminergic medications. Patients with migraine also have an increased density
of dopamine receptors on peripheral lymphocytes when compared to the density in
controls, which may reflect an underactive dopaminergic system. In terms of genetics,
there is evidence that migraine is associated with the dopamine allele ß-hydroxylase.
Psychological Factors Associated with Headaches
Depression
Depression often is associated with the presence of headaches (Nicholson et al.,
2007). As described by Nicholson et al., (2007), depression is characterized by feelings
of sadness, despair, emptiness, and/or lack of pleasure in activities that occur almost
every day for more than 2 weeks. A prospective designed study, measuring the incidence
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of the first onset of major depression and headaches during a 2-year follow-up study
found a comorbidity between headache and depression (Breslau, Lipton, Stewart,
Schultz, & Welch, 2003). There are several hypotheses regarding the relationship
between the two disorders: (a) there is a shared etiology (whether inherited or acquired),
thereby creating vulnerability for the development of both disorders; (b) migraine leads to
worry and dysphoria, thereby increasing the risk for depression; (c) depression leads to
migraines and/or impairs the ability to cope with pain; and (d) there is a bidirectional
relationship between depression and migraine, with one disorder increasing the risk for
the other (Breslau et al., 2003). Much of the following research is aimed at shedding light
on the relationship between pain and depression.
Research has not led to a clear understanding about whether there is a shared
etiology or a bidirectional relationship between depression and headaches (Breslau et al.,
2003). When patients with migraine with and without major depression were compared,
patients with major depression had headaches at a greater severity but were not at risk for
headache persistence (Breslau et al., 2003). Likewise, the risk for a first onset of major
depression increased six-fold with the presence of migraine and a history of one or more
depressive symptoms (Breslau et al., 2003). However, patients with and without major
depression did not differ on the frequency of migraine attacks or on the persistence of
migraine after a 2-year follow-up study (Breslau et al., 2003). Likewise, Breslau et al.
(2003) found that there was no increase in headache-related disability over time for
people with persistent migraine and a history of comorbid major depression.
Interestingly, a correlational study involving inpatient treatment of chronic headache
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disorders found that reductions in depression scores as measured by the Beck Depression
Inventory (BDI) were not correlated with a reduction in the frequency of severe headache
(Hoodin, Brines, Lake, Wilson, & Saper, 2000). Research supporting a bidirectional
relationship between depression and headaches is conflicting, perhaps because of the
length of the follow-up period in the studies.
More definite evidence for the shared etiology hypothesis is found when
researchers compared patients with migraine with patients with other severe types of
headache (Breslau et al., 2003). Unlike with migraine, the presence of other severe
headache disorders did not predict the transition of one or more depressive symptoms to
the full criteria of major depression (Breslau et al., 2003). Therefore, one can assume that
the major depression associated with migraine is not simply a reaction of distress from
pain, because people with severe headaches then also would have depressive symptoms
transformed into major depression (Breslau et al., 2003). According to Breslau et al.
(2003), there is a shared etiology between migraine and depression, which is probably not
a result of a predisposition to experience or report both physical and psychological
symptoms of distress. Instead, they propose that the shared etiology is an imbalance of
hormones or neurotransmitters. Other studies suggest that the shared etiology results from
a common pathophysiology between both disorders (Cahill & Murphy, 2004). For
example, both migraine attacks and depressive episodes have a sudden onset, a similar
course over time, and a partially overlapping treatment responsiveness (Cahill & Murphy,
2004).
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Even in the absence of a major depressive disorder, there is a relationship between
negative affect and headaches (Nicholson et al., 2007). Negative affect can increase the
likelihood of having a headache, the intensity of pain, and the amount of headache
disability. Research suggests that sufferers from headache experience more dysphoria as
compared to people who do not suffer from headache. Likewise, negative affect creates
more opportunities for stress to trigger a headache. Some studies suggest that negative
affect increases severity of head pain (Nicholson et al., 2007). The presence of depression
and dysphoria is a negative treatment indicator. Not only do they negatively influence
patients’ satisfaction with health care, but in terms of treatment response with general
medical conditions, depression and dysphoria can interfere with patients’ ability to adapt
to lifestyle changes, recover from procedures, and adhere to medication regimens
(Cruess, Minor, Antoni & Millon, 2007; Nicholson et al., 2007). It appears that perhaps
with some headache types, dysphoria negatively influences the disorder (Nicholson et al.,
2007).
Researchers analyzed the relationship between mood and pain in experimental
studies (Keefe, Lumley, Anderson, Lynch, & Carson, 2001). Pain-free participants acted
roles of positive, negative, or neutral mood states and then engaged in a cold-pressure
pain tolerance task. Results showed that participants who acted the negative mood state
showed a significant decrease in cold-pressure pain tolerance. Conversely, participants
acting the positive mood condition showed a significant increase in cold-pressure pain
tolerance. Results suggest that negative mood leads to increased reported experimental
pain and potentially lower pain tolerance.
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To sort out the relationship between pain and depression, some studies examined
the effects of a depressive history on pain disorders (Tennen, Affleck, & Zautra, 2006).
Even years after having a major depressive episode, patients with rheumatoid arthritis
reported higher levels of pain, as compared to patients without a history of depression.
However, higher levels of pain were reported only during high levels of distress.
Likewise, patients with primary fibromyalgia syndrome (PFS) and a history of depression
vented emotions more and perceived a decline in coping ability with rises in pain, as
compared to patients with PFS and no history of depression. Interestingly, depressive
symptoms in patients with PFS in the absence of a history of depression did not impact
pain significantly unless the patients had a history of depression. However, higher levels
of depressive symptoms were associated with lower moods on painful days. Patients with
PFS who were formerly depressed used ineffective coping strategies when pain
increased. Perhaps previously depressed patients had an erosion of resources and/or a
vulnerability for using ineffective coping strategies, especially when in pain.
Another study investigated the relationship between depression and chronic pain
by looking at the similar and different characteristics of depression and pain and at the
impact of depression on pain outcomes (Korff & Simon, 1996). Korff and Simon (1996)
found that not all dimensions of chronic pain are associated with depression. Contrary to
previously mentioned studies, pain intensity was not significantly associated with
increased depression. However, Korff and Simon (1996) found that interference with
activities was a strong predictor of higher levels of depression. Additionally, the number
of pain days in the previous 6 months combined with the number of pain sites was
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significantly associated with depressive symptoms. Diffuse pain also was associated with
increased depressive symptoms. In fact, the combination of diffuse somatic symptoms
(other than pain) and interference with activities (disability) was associated with
psychological distress. Korff and Simon (1996) suggested that people reporting diffuse
somatic symptoms may have a heightened responsiveness to physical and psychological
stressors. They proposed that the responsivity is related to the same process that creates
comorbidity between physical and psychological problems.
Another study found connections among somatic symptoms, depression, and
headache (Tietjen et. al., 2007). Chronic headache was associated with increased severity
of somatic symptoms and increased frequency of major depressive disorder. Common
somatic symptoms other than head pain included extremity/joint pain, back pain, and
stomach pain. Somatic symptoms that overlapped with depressive symptoms were almost
twice as likely as pain symptoms for sufferers of chronic headache in the study. Tietjen et
al. (2007) also found that increases in somatic symptoms were associated with increases
in depression.
The interrelationship among somatic symptoms, depression, and headache should
be interpreted with caution (Tietjen et al., 2007). For example, the increase in depression
could result from an overlap of similarity between depressive and somatic symptoms
(Tietjen et al., 2007). Along the same lines, another study found a strong association
between headaches and somatoform and psychological disorders (Bensenor, Tofoli, &
Andrade, 2003). Bensenor et al. (2003) attributed the strong association between
headaches and somatoform disorders to the overlap of similar symptomatology.
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However, one study suggested that somatic and depressive symptoms are distinct owing
to the finding that somatic symptoms predicted major depression in the following year
(Tietjen et al., 2007).
According to Tietjen et al. (2007), there is probably a synergistic relationship
between the related variables of depression and headache. For example, while one or two
pain-related variables may not impact mood, many variables combined may result in
depression. Tietjen et al. (2007) found that people with frequent headache, severe
headache-related disability, and multiple somatic symptoms are likely to have active
major depressive disorder. They also found that as education and income decreased,
severity of headache frequency, headache impact, somatic symptoms, and depression
increased. Apparently, rather than a simple, bidirectional relationship between headache
and depression, there is probably a synergistic relationship between the two variables,
which may be linked to a dysfunction of the serotonergic system.
According to Korff and Simon (1996), the associations among diffuse physical
symptoms, migraines, and depression are the result of a common predisposition between
migraine and psychological disorders rather than of a causal relationship between the
disorders. In support against a causal relationship, Korff and Simon (1996) reported that
people with chronic depression did not have an increased risk for the first onset of back
pain, stomach pain, or temporomandibular pain, as compared to a control group.
However, Korff and Simon (1996) did not present research specific to migraine and
chronic depression.
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While some research suggests that depression does not increase the risk for
developing pain disorders, other research suggests that pain may increase the risk for
developing depression under certain circumstances (Korff & Simon, 1996). Research
suggests that pain influences depression over time through loss of social reinforcement
and learned helplessness. However, the length of chronic pain did not predict the onset of
depression. Rather, unimproved pain predicted the onset of depression. For example,
after 7 weeks, patients with unimproved back pain were significantly more depressed
than patients whose pain had improved. According to Koroff and Simon (1996),
depression seems to manifest as a result of an incomplete recovery, rather than from
chronicity. Again, Koroff and Simon (1996) did not present research specific to migraine
and depression.
Anxiety
Anxiety and migraine are frequently comorbid disorders, begging the same
question asked about depression and headache: are they part of the same spectrum or
separate disorders? (Sheftell & Atlas, 2002). Both disorders sometimes can be treated
with the same medications, suggesting a related etiology. Likewise, anxiety disorders are
more prevalent among migraine patients than among the general population. According
to Sheftell and Atlas (2002), while there is no definite answer, research suggests that
there are shared mechanisms of action that account for the etiology of anxiety,
depression, and headaches.
While research has focused more on the comorbidity between depression and
headache, anxiety may be even more prominent in patients with headache (Nicholson et
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al., 2007). Anxiety is defined as worry, fear, uneasiness, and apprehensiveness
(Nicholson et al., 2007). It can result from real or perceived situations for which
outcomes are unpredictable, uncontrollable, or unobtainable (Nicholson et al., 2007).
Anxiety is more chronic during unpredictable events, such as headaches (Sheftell &
Atlas, 2002). Situations provoking anxiety can be either specific (i.e., a work evaluation)
or more nebulous (i.e., future career) (Nicholson et al., 2007). Nicholson et al. (2007)
reported that individuals with headaches have more anxiety than individuals without
them. Correspondingly, feelings of anxiety and stress are the most common headache
triggers (Nicholson et al., 2007). Nicholson et al. (2007) reported that anxiety also can
exacerbate intensity and frequency of head pain.
Anxiety significantly contributes to headache-related disability (Nicholson et al.,
2007). According to Nash, Williams, Nicholson, and Trask (2006), patients with
headache and increased anxiety had more disability, a poorer quality of life, and higher
health care costs than did patients without anxiety. Specifically, one study found that
pain-related anxiety accounted for about 14% of the variance of headache-related
disability (Nash et al., 2006). Likewise, even when controlling for pain, headache-control
beliefs, and emotional distress, physiological anxiety uniquely and significantly
contributed to disability (Nash et al., 2006). Additionally, less anxiety after a period of 6
months predicted a lesser impact of headache interference as compared to a reduction of
headache frequency and medication change (Nicholson et al., 2007).
Nash et al. (2006) proposed that pain-related anxiety contributes to disability.
According to the fear avoidance model, pain can trigger cognitive, emotional, and
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physiological anxiety responses. Pain may trigger cognitions regarding inability to cope,
activity exacerbating pain, or worry about the inability to complete scheduled activities.
Pain also may create the physiological responses of anxiety through sympathetic arousal.
In turn, the psychological and physiological responses of anxiety may create a fear of
pain, avoidance of activities, and hypervigilance for the preliminary signs of pain.
Hypervigilance for pain can result from fear of pain, severity of pain, and
avoidance of pain (Keefe et al., 2001). Fear of pain can lead to avoidance of stimuli that
may trigger pain, such as movement, social activities, employment, and daily routine
activities (Keefe et al., 2001). A fear of pain contributed to greater disability and a
worsening of pain in patients with chronic pain (Keefe et al., 2001; Siedliecki & Good,
2006). Likewise, one study found that a high fear of pain and severity of pain interfered
with attention, potentially as a result of hypervigilance for pain (Keefe et al., 2001).
While research on the relationship between headaches and anxiety sensitivity is in
its infancy, anxiety sensitivity may increase headache-related disability (Nicholson et al.,
2007). Anxiety sensitivity is a cognitive process defined as the tendency to react fearfully
to unusual bodily sensations, (i.e., a headache is a brain tumor). The main component of
AS is the catastrophic interpretation, (thinking the worst about bodily sensations), which
creates fear. Disability can occur when innocuous sensations misinterpreted as headache
triggers lead to an avoidance of the specific activities occurring around the sensations
and/or of activities in general.
According to Nicholson et al. (2007), anxiety sensitivity also can increase the
likelihood of precipitating a headache, making headache pain worse. Nicholson et al.
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(2007) proposed that the negative effects of anxiety sensitivity occur when the
catastrophic interpretation leads to sympathetic activation, which may trigger head pain
or precipitate a headache. The increased pain reinforces the catastrophic interpretation,
thereby increasing sympathetic arousal and consequently perpetuating a vicious cycle that
may lead to panic attacks (Nicholson et al., 2007). One laboratory study found that
anxiety sensitivity accounted for higher pain ratings among patients with panic disorder
as compared to controls (Keefe et al., 2001).
Some research suggests that fear and anxiety have different relationships with
pain (Keefe et al., 2001). One study examined the differences. Participants were assigned
to one of three emotion conditions: fear by a brief shock, anxiety by a threat of shock,
and a neutral condition. Before and after emotional inductions, participants were tested
on their pain threshold to radiant heat. Anxiety and fear produced different effects on
pain threshold as measured by finger withdrawal. Anxiety resulted in increased pain
reactivity, while fear resulted in decreased pain reactivity. While the results coincide with
animal-study findings, a previously mentioned study found that fear worsens pain in
patients with pain. Therefore, more research is needed to determine the role of fear and
anxiety during the pain process in experimental and naturalistic settings with the general
population and patients with pain.
Pain Sensitization
Negative emotions, such as depression and anxiety, are not only consequences of
pain but also part of the pain process, particularly the development of pain sensitization
(Janssen, 2002). Negative emotions serve several functions during the pain process.
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Avoidance caused by depression or anxiety promotes recovery. Anxiety causes vigilance
that prevents further harm. However, once pain becomes chronic, negative emotions are
no longer adaptive. Negative emotions caused by chronic pain may cause ongoing
physiological reactivity (i.e., enhanced sympathetic activation and muscle tension), along
with low vagal tone and hypervigilance for pain, contributing to a pain sensitization. In
turn, pain sensitization causes misdirected attempts to escape or avoid pain, which
reinforces negative emotions, resulting in functional disability.
Psychiatric Comorbidity
With the presence of comorbid psychiatric and medical conditions, health-care
utilization increases and health perception declines (Kalaydjian & Merikangas, 2008).
However, psychiatric comorbidity has more of a detrimental effect on the headache
disorder (Kalaydjian & Merikangas, 2008). Untreated depression may account for some
pain-treatment failures (Kalaydjian & Merikangas, 2008). Of one study sample, 19 % had
at least one comorbid psychiatric disorder (Kalaydjian & Merikangas, 2008). Dysthymia
was the most common comorbid disorder of the depressive disorders, while Generalized
Anxiety Disorder and Panic Disorder were the most common comorbidities of the anxiety
disorders (Bensenor et al., 2003; Kalaydjian & Merikangas, 2008). Interestingly, both
Generalized Anxiety Disorder and Dysthymia are the most chronic disorders in their
respective categories.
Suicide is a significant concern among patients with migraine. Cahill and Murphy
(2004) reported an elevated risk of suicide among patients with Migraine with Aura and
Migraine without Aura. Of particular risk are patients with Migraine with Aura, with
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comorbid depressive disorders. For example, with depression alone, the odds of a suicide
attempt are 7.8 % as compared to 23.2 % for depressive disorders comorbid with
Migraine with Aura. Even after controlling for psychiatric disorders, both Migraine with
Aura and Migraine without Aura were significantly associated with suicidal ideation and
attempts.
Learned Helplessness
According to Sheftell and Atlas (2002), helplessness is a psychological state that
can occur from an uncontrollable situation or a situation perceived as uncontrollable,
such as headaches. A response pattern of helplessness can lead to a general response of
learned helplessness, which can contribute to depression and anxiety (Sheftell & Atlas,
2002). Overmier (2002) reported that learned helplessness is a state resulting from a loss
of control over one’s environment or over events that are especially noxious or painful.
Learned helplessness is a state characterized by impaired motivation to initiate coping
behaviors or learn new ways to cope (Overmier, 2002). A state of learned helplessness
can last hours, days, or weeks (Overmier, 2002). It is likely to develop when an
individual is exposed to unpredictable, aversive events outside of one’s control
(Overmier, 2002). One theory proposed that helplessness is responsible for the
comorbidity between migraine and psychiatric disorders (Sheftell & Atlas, 2002).
Stages of Change
Some studies found that readiness to manage pain, as measured by the Pain Stages
of Change Questionnaire (PSOCQ), affected treatment outcomes (Hadjistavropoulos &
Shymkiw, 2007). The precontemplation subscale measures a lack of intention to use self-
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management techniques for pain, while the action subscale measures an active
engagement in managing pain. Unexpectedly, a high intention to manage pain predicted
dropout of a 10-session cognitive-behavioral treatment program. However,
Hadjistavropoulos and Shymkiw (2007) reported that high intention to manage pain and
high active engagement were associated with less depression and more use of coping
strategies. Patients who entered treatment with high active engagement and continued to
increase their engagement early in treatment benefited the most from multidisciplinary
treatment. Likewise, individuals with high active engagement for managing pain reported
higher self-efficacy, internal control over pain, and more satisfaction with information
given by their primary-care provider.
On the other hand, a low intention to self-manage pain correlated significantly
with high levels of pain severity, pain-related interference, depression, and pain-related
anxiety (Hadjistavropoulos & Shymkiw, 2007). Likewise, individuals with low intention
to self-manage pain reported less control and self-efficacy over pain. Interestingly,
Hadjistavropoulos and Shymkiw (2007) found that a powerful-others or chance locus of
control predicted low intention to self-manage pain.
Headache-treatment outcome studies found psychological indicators for
medication response and nonresponse (Lucas et al., 2007). Specifically, anxiety and high
emotional distress, as measured by the Hospital Anxiety and Depression Scale (HAD),
were associated with a greater likelihood of not responding to medication treatment.
Lucas et al. (2007) proposed that anxiety and depression play a role in poor medication
compliance, which contributes to nonresponse to medication treatment. More
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specifically, they reported that catastrophizing, less use of positive reinterpretation to
cope, and avoidance were characteristics associated with nonresponders. Interestingly,
acceptance as a coping strategy also was associated with nonresponders. According to
Lucas et al. (2007), acceptance may reflect helplessness and unwillingness to take control
of headaches. On the other hand, it may reflect a transition from seeking treatment to
adaptation to the disorder. Lucas et al. (2007) also reported that the use of positive
reinterpretation as a coping strategy was associated with treatment response.
Neuroticism
Neuroticism is a personality characteristic associated with maladaptive coping
skills, the onset of new migraine headache disorder, depression, and other pain-related
variables (Keefe et al., 2001; Tennen et al., 2006). Neuroticism is defined as the
disposition to experience and report aversive emotions (Keefe et al., 2001). People with
high neuroticism may respond to pain in maladaptive ways, particularly with
catastrophizing (Keefe et al., 2001). One prospective study assessed neuroticism at
baseline along with the new onset of migraine headaches over a 5-year period. The study
found that the risk of developing migraine increased directly with neuroticism scores
among women (Keefe et al., 2001). Therefore, according to Keefe et al. (2001), negative
emotional states not only are correlated with pain problems, but also are risk factors for
pain onset and/or exacerbation. Neuroticism also is linked to pain intensity, pain-related
appraisals, low self-efficacy beliefs, and low pain control appraisals (Hadjistavropoulos
& Shymkiw, 2007; Tennen et al., 2006).
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In addition to neuroticism, Huber and Henrich (2003) researched the association
between personality characteristics and headaches. They found that neuroticism, as
measured by the neurotic triad on the Minnesota Multiphasic Personality Inventory
(MMPI-2), and introversion are elevated in patients with migraine. However, headache
and bodily symptoms are shared items on the neuroticism score, which contributed
somewhat to elevations. Huber and Henrich (2003) also reported a significant correlation
between the neuroticism score and headache duration (total time of headaches per week).
Social conformity also is a personality characteristic associated with patients with
migraine. Additionally, Huber and Henrich (2003) reported that longitudinal studies
showed a strong and consistent association between migraines and a stress-reactive
personality, characterized by nervousness, sensitivity, and tendency to worry.
Huber and Henrich (2003) reported evidence against trait stability indefinitely
influencing headaches. According to Huber and Henrich (2003), the elevated introversion
and neuroticism scores reversed with successful headache treatment. Likewise, the fact
that stress can trigger the onset of migraines and increase migraine attacks is evidence
against a “migraine personality.” Instead, Huber and Henrich (2003) proposed an
interaction between personality and environment. Specifically, the personality traits
associated with migraine are proposed to result from a lower tolerance to stress,
ineffective coping strategies, a limited ability to relax, and an increased focus on
achievement.
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Stress and Coping
Appraisals of environmental events can create negative emotional states, which
can lead to stress (Keefe et al., 2001). Stress is defined as a process of appraisal of events
and the resources to cope with the events (Keefe et al., 2001). There are two types of
appraisal: primary appraisal and secondary appraisal (Hassinger, Semenchuk, & O’Brien,
1999). In primary appraisal, the person determines the significance of the event. In
secondary appraisal, the person determines available resources (Hassinger et al., 1999).
The combined primary and secondary appraisals lead to an evaluation of the stress level
(Hassinger et al., 1999). The appraisal of events can affect the manifestation of the stress
and the coping efforts used to reduce stress (Hassinger et al., 1999). Additionally, coping
mechanisms can influence stress-related health symptoms, such as pain (Hassinger et al.,
1999).
Hassinger et al. (1999) reported that headache sufferers’ appraisal of stress is
different from the appraisal by headache-free controls (Hassinger et al., 1999). For
example, those who suffered with headache reported more daily hassles and rated the
hassles as more distressing and disturbing when compared to the reports and ratings by
headache-free individuals (Hassinger et al., 1999). Hassinger et al. (1999) proposed that
when the perception of stress by those who suffer with headache is more negative than
the typical perception, they may exacerbate their head pain.
According to Hassinger et al. (1999), headache-free individuals and those with
tension headache cope with pain differently. For example, Hassinger et al. (1999)
reported that those with tension headache responded to acute pain with more
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catastrophizing than that of the control group. Hassinger et al. (1999) also reported that
those with headache cope with stress less effectively than do controls. According to
Huber and Henrich (2003), those with headache cope with stress by using coping skills,
such as wishful thinking, problem avoidance, and self-criticism, which are thought to
maintain stress rather than to reduce it. Likewise, those with headache use the stressreducing coping strategy of social support less frequently than do headache-free controls
(Hassinger et al., 1999). While there were differences in appraisal of and coping with
pain among the headache-free, headache, and migraine groups, there were no differences
among the groups in coping with cognitive stressors (Hassinger et al., 1999).
Differences in appraisal of and coping with stress were found also between
patients with migraine and controls, with patients with migraine using maladaptive
coping skills (Hassinger et al., 1999; Huber & Henrich, 2003). In a laboratory study,
while patients with migraine reported a cold pressor task as more painful than did
controls, they did not indicate the experience of pain any sooner than did controls
(Hassinger et al., 1999). Results suggest that patients with migraine do not have a lower
pain tolerance to the acute pain task (Hassinger et al., 1999). Hassinger et al. (1999)
proposed that patients with migraine may have learned to appraise pain as more
troublesome to lessen responsibility. In clinical studies, patients with migraine used more
maladaptive coping strategies when dealing with pain and stress, such as catastrophizing
and social withdrawal (Hassinger et al., 1999). However, in the laboratory study,
catastrophizing was not found to be a significant reliant coping strategy for patients with
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migraine. In terms of coping with cognitive stressors, the laboratory study found that
patients with migraine used wishful thinking and self-criticism (Hassinger et al., 1999).
There are several possibilities for the relationship between headaches and
maladaptive coping strategies (Hassinger et al., 1999). One research-based theory
proposed that using less effective coping strategies to deal with stress and pain can
exacerbate stress and pain (Hassinger et al., 1999). However, because most studies are
quasiexperimental, other possibilities have been considered. For example, pain may
create a mobilization effect to use any coping strategy available, whether adaptive or not
(Hassinger et al., 1999). Additionally, maladaptive strategies may work for dealing with
headaches, but could be maladaptive when used in other situations (Hassinger et al.,
1999). Another theory proposed that there is a reciprocal relationship between
maladaptive coping strategies and headaches, specifically that they both may increase the
risk for the other to occur (Hassinger et al., 1999).
Studies show that maladaptive coping strategies and stress are associated with
poorer adjustment and outcomes for patients with pain (Hassinger et al., 1999). With
patients suffering from chronic low-back pain and arthritis, catastrophizing predicted
increased pain levels, psychological distress, and decreased health status (Hassinger et
al., 1999). Longitudinal studies with patients with rheumatoid arthritis and fibromyalgia
found that passive coping was associated with depression, psychosocial impairment, and
increased pain behaviors (Hassinger et al., 1999). Huber and Henrich (2003) reported that
with patients with migraine, fatigue-induced stress led to longer recovery time from
tension and depression. According to Hassinger et al. (1999), prolonged stress may lead
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to an increased comorbidity of depressive and anxiety disorders for patients with
headache.
Rothermund and Brandtstädter (2003) conducted research about accommodative
and assimilative ways of coping with loss of functional deficits. They found that when
functional impairments presented later in life, compensatory strategies that are
assimilative in nature, (i.e., obtaining additional resources to avoid losses in order to
maintain personal standards) increased for individuals up until the age of 70 years, and
declined thereafter. They proposed that functional impairments initially prompt
individuals to seek out compensatory strategies. When those strategies are no longer
efficient in maintaining previous levels of functioning, there is a reduction in their use.
When compensatory strategies are no longer efficient, self-evaluations become negative.
However, Rothermund and Brandtstädter (2003) proposed that with accommodative
coping, the negative effect can be buffered by adjusting personal standards.
Catastrophizing. Catastrophizing is a maladaptive coping mechanism associated
with negative pain-related outcomes (Keefe et al., 2001). Despite the negative outcomes,
this mechanism seems to serve a purpose for patients with pain. Catastrophizing is
defined as the tendency to focus on and exaggerate pain as a threat and negatively
evaluate the ability to deal with pain. The coping perspective proposes that people who
catastrophize may use it to communicate their need for emotional support. Specifically,
people may catastrophize to elicit the help of others and to reduce future expectations of
behavioral activity. Catastrophizing is linked to higher self-reported pain, higher levels of
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overt pain behavior, more pain-related disability, and increased use of pain medication
and health-care services.
Kemp, Ersek, and Turner (2005) found associations between demographic
characteristics and coping strategies for patients with pain. Both female and male older
adult patients reported that spiritual practice and physical exercise were the most helpful
coping strategies. Spiritual practice was reported as the third most common pain-coping
strategy, while regular exercise was reported as the second most common. Religious
coping strategies for pain management were most commonly reported by women and
racial minorities.
Spirituality. In a literature review, Rippentrop (2005) found that patients with
chronic pain use prayer as one way to cope with pain. In one study of individuals with
musculoskeletal pain, prayer was the most used nonconventional pain management
remedy. Another study found that minorities with arthritis used prayer to cope with pain.
For example, 92% of African Americans and 50% of Hispanics with arthritis used prayer
to cope with pain. Likewise, a qualitative study of Latina women with arthritis found that
prayer and religious beliefs or activities were the second most used coping strategies for
pain.
While prayer and spirituality are used frequently as coping mechanisms, spiritual
coping strategies may not be effective ways to cope with pain (Rippentrop, 2005). Some
research suggests that prayer characterized by hope is associated with increased pain,
whereas other research suggests that prayer is associated with reduced pain. Spiritual
coping is complex, and many coping questionnaires have a religious coping subscale with
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a few items that capture negative and/or positive effects of religious coping. Some studies
found no relationship between spirituality and pain. One study found that while
spirituality religious coping was not associated with quality of life, it was associated with
positive affect and psychological well-being. For example, spirituality as measured by the
Spiritual Transcendence Scale, was an independent predictor of positive affect and selfratings of health on the Short Form Health Survey (SF-36) in a sample of patients with
rheumatoid arthritis.
Social support. For some patients with pain, social support leads to positive
outcomes, while social isolation leads to negative outcomes (Zautra, Hamilton, & Burke,
1999). Social isolation predicted greater pain and psychological dysfunction in patients
with fibromyalgia. For some individuals, social support plays a critical role in the choice
of coping strategies they use. For example, women with rheumatoid arthritis chose
coping strategies based on the responses of their social network and personal disposition.
Women with critical spouses used more maladaptive coping strategies. Older adults with
negative social relations reported having more difficulty coping with chronic health
problems. Zautra, Hamilton, and Burke, (1999) reported that positive interpersonal
interactions may preserve quality of life for individuals with fibromyalgia, while social
withdrawal during pain episodes may make the individual more vulnerable to stress over
time. Continual withdrawal from social interaction may weaken the ability to cope
effectively, thus leading to maladaptive ways of coping. Helping patients with
fibromyalgia find ways to interact positively with others even during pain attacks can
improve well-being.
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Hurwitz, Goldstein, Morgenstern, and Chiang (2006) also reported positive
effects of social support. In a study of patients with neck pain, those who reported using
social support and positive self-assurance had less pain and disability 6 months after
treatment. Patients who had a lack of support from co-workers, family, and friends had
more symptoms. Likewise, active coping, such as seeking out social support, is
associated with reduced levels of pain, or no change in pain. On the other hand, passive
coping, such as social isolation, is associated with high levels of ongoing pain.
Optimism. Ferreira and Sherman (2007) defined optimism as having a positive
outlook on life, which is part of one’s temperament and related to adaptation to chronic
illness. According to Ferreira and Sherman, optimism is related to a better reported
quality of life and promotes healthier habits and coping with chronic illness. Depending
on the circumstances of the chronic illness, the role of optimism may vary. For example,
if the chronic illness can be controlled at least in part by the patient’s behaviors, optimism
is associated with better functioning. Having positive outcome expectancies predicted
positive outcomes, such as positive affect, psychological well-being, and the use of
problem-focused coping strategies.
Studies show relationships among optimism, pain conditions, and chronic illness
(Affleck, Tennen, & Apter, 2001; Treharne, Kitas, Lyons, & Booth, 2005). For patients
in the early stages of rheumatoid arthritis, a chronic, painful arthritic condition, optimism
was related to less depression, more life satisfaction, and lower levels of pain (Treharne
et al., 2005). However, when the disease was established, optimism was associated with
higher pain levels (Treharne et al., 2005). Affleck et al. (2001) reported that patients with
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rheumatoid arthritis reported more pessimism than optimism being associated with
negative daily mood, more functional disability, negative daily events, and poorer sleep.
Individuals who were more optimistic reported having more cognitive coping strategies,
social support, and control over pain, despite still having pessimistic moments (Affleck et
al., 2001). Affleck et al. (2001) reported that negative daily experiences, coping
strategies, and neuroticism in combination with pessimism or optimism affected painrelated outcomes. Optimists may have better health outcomes because they cope better
with stress and difficult situations, resulting in less distress and impact on the physical
condition (Affleck et al., 2001).
Demographic Factors Associated with Headaches
Bensenor et al. (2003) reported demographic and psychological factors associated
with headache. Specifically, they found that headache attributed to psychological factors
(nervousness or mental illness) peaked for both genders in the 25-34 year age range.
However, after age 54 year, the frequency of a psychological contribution to headaches
decreased. Headache attributed to lifestyle and/or physical conditions (i.e., fever, clinical,
or neurological disorders) or to psychological conditions were 1.5 to 2.9 times more
common for women than for men (Bensenor et al., 2003). Additionally, the frequency of
headache problems attributed to lifestyle and/or physical conditions increased with age,
up until the 55-64 year age range (Bensenor et al., 2003). In 1998, chronic headache
disorders, such as Chronic Tension Type Headache, Chronic Migraine, and Frequent
Headache of Other Types, occurred at a median age of 39 years in both men and women
(Bensenor et al., 2003). Prevalence for Chronic Tension Type Headache, Chronic

LOS AND INPATIENT HEADACHE UNIT

45

Migraine, and Frequent Headache of Other Types appeared to be higher for people in
their 40’s and 50’s and dropped to the lowest levels after age 55 years (Freitag et al.,
2004). Demographic risk factors associated with Chronic Daily Headache include female
gender; divorced, separated, or widowed marital status; and an education level of less
than high school graduate (Marmura, Rosen, Abbas & Silberstein, 2009).
According to Bigal, Liberman, and Lipton (2006), headache disorders change
with age. Patients in younger age ranges have a higher proportion of unilateral pain, pain
aggravated by exercise, photophobia, and phonophobia (Bigal et al., 2006). Moreover,
with increasing age, migraine attacks are typically less frequent and milder (Bigal et al.,
2006; Kunkel, 2006;). However, while nausea and migraine disability lessen with age,
total global amnesia and transient migrainous accompaniments are more frequent
(Kunkel, 2006). Bigal et al. (2006) also found that aura was more common with age.
With older patients, new-onset migraine is more likely to have secondary causes (Kunkel,
2006).
Bigal et al. (2006) reported that the prevalence of headache disorders varies
among age groups. The peak prevalence of migraine occurred between the ages of 30 to
39 years (Bigal et al., 2006). Probable Migraine was more common than migraine in the
younger and older ages (18-29 years; 70+ years) (Bigal et al., 2006). Transformed
migraine to Chronic Daily Headache was more prevalent in middle- and older-age
subjects, suggesting that over time some patients transform to Chronic Daily Headache
(Bigal et al., 2006). Tension-Type Headache is more common before the age of 45 years,
but it also can occur after the age of 45 years (Bigal et al., 2006). Late-onset Tension-
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Type Headache is likely caused by excessive muscle tension aggravated by arthritis, poor
posture, visual abnormalities, and temporomandibular joint disorders (Kunkel, 2006).
Kunkel (2006) reported that Tension-Type Headache before age 45 years is usually
associated with depression and stress.
According to Thorn et al. (2004), there are pain differences between men and
women. Particularly, women report more intense pain and have a lower threshold for pain
than men. Thorn et al. reported that there are both biological and psychosocial
explanations for the gender differences. Catastrophizing and gender roles are two
psychosocial variables proposed to influence the relationship between gender and pain.
According to Thorn et al. (2004), gender differences may account for the higher
prevalence of headache disorders among women.
According to Thorn et al. (2004), the impact of societal gender roles on
personality contributes to the pain responsivity differences between genders. They
defined gender roles as characteristics of gender differences proscribed by society. For
example, in the United States, stoicism is attributed to men and sensitivity is attributed to
women. Individuals classified as masculine had higher pain thresholds and significantly
lower pain-intensity ratings as compared to individuals classified as feminine (Thorn et
al., 2004).
Some studies suggest that catastrophizing is a mediator between gender and painrelated outcomes (Keefe et al., 2001; Thorn et al., 2004). According to Keefe et al.
(2001), catastrophizing may explain some gender differences of pain reporting.
Compared to men, female patients with osteoarthritis who catastrophized had higher
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reported levels of pain, physical disability, and pain behavior (Keefe et al., 2001).
However, when catastrophizing was controlled for, the gender effects were eliminated
(Keefe et al., 2001). Contrarily, Thorn et al. (2004) reported that in a cold pressor task,
catastrophizing measured before the task showed no significant effect on subjective pain
reports. Likewise, there was only a slight effect from catastrophizing on pain tolerance
(Thorn et al., 2004).
The emotional vulnerability trait, which is more prevalent in women, may
partially explain the gender pain differences (Thorn et al., 2004). Thorn et al. (2004)
reported that when the emotional vulnerability trait was controlled for statistically, the
gender differences in pain responses were reduced. Thorn et al. (2004) proposed that the
emotional vulnerability trait is a mediating link between gender differences, pain
tolerance, and subjective pain ratings. Interestingly, individuals classified as androgynous
showed no significant differences in pain ratings as compared to masculine and feminine
groups.
Thorn et al. (2004) reported that the emotional vulnerability trait is responsible for
catastrophizing and the gender differences of pain. When the emotional vulnerability trait
and the factor of a whiny, complaining attitude were statistically controlled for, men and
women did not differ in catastrophizing. According to Thorn et al. (2004) catastrophizing
is likely a characteristic of the emotional vulnerability trait. Therefore, someone with a
stable pattern of emotional vulnerability may have the tendency to catastrophize in
response to pain, which is consistent with the stress diathesis model of chronic pain.

LOS AND INPATIENT HEADACHE UNIT

48

According to Thorn et al. (2004), women are more likely than men to develop the
emotional vulnerability trait as a result of a history of pain and/or negative life events.
Women are more likely than men to have persistent recurrent pain from chronic nonlifethreatening conditions. Additionally, the multiple role responsibilities women have may
lead to greater perceived stress, a higher prevalence of depression, and more negative life
events in general. However, Thorn et al. (2004) acknowledged that women may become
more emotionally vulnerable at least partly because of biological predispositions for pain
sensitivity.
Minority patients have unique chronic pain experiences (Baker, Buchanan, &
Corson, 2008). African American people reported more pain and less control over pain
than reported by Caucasian people. Additionally, African American women are
disproportionately affected by more chronic medical diseases, rate their health as poor
more often, and report less functional capacities when compared to Caucasian women.
The differences between Caucasian and African American women exist even after
controlling for income and education.
Baker et al. (2008) examined pain characteristics of a sample of African
American women aged 61 - 80 years to determine unique pain characteristics. They
found that women who were younger reported greater pain intensity. Baker et al.
proposed that the age difference may be related to experience in developing coping skills.
Older women may have learned better ways to cope with physical or psychological health
issues. Baker et al. also proposed that older women may have acclimated to higher pain
thresholds over the years, thereby reducing the perception of pain intensity. The age
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effect also could have resulted from a cohort effect. For example, the group of older
women may have had biological vitality or they may have developed psychological
strength or coping abilities that allowed them to mitigate pain intensity. Baker et al. did
not report the age range they considered as younger or older.
Baker et al. (2008) found differences with locus of control (LOC), depression, and
pain between African American women reported in prior research and other demographic
populations. In the sample of African American women aged 61 - 80 years, those who
experienced greater pain intensity reported more depressive symptoms and an internal
LOC. In other studies, an internal LOC was related to better pain outcomes, perhaps
suggesting that LOC functions differently for this sample. Baker et al. (2008) proposed
that for older African American women, perceived responsibility for pain may create
self-blame instead of motivation to reduce pain severity. They reported that depressive
symptoms in this population may be misrepresented. Chronic medical symptoms
common in the older African American population of women can resemble depressive
symptoms, making depression difficult to be distinguished from a medical condition.
Psychological and Medical Factors Associated with Treatment Outcome
Research has found relationships between treatment outcome and health LOC,
Medication Overuse Headache, and personality disorders (Lake, Saper, & Hamel, 2009;
Primavera & Kaiser, 1993). Primavera and Kaiser (1993) found that inpatients with a
balanced health LOC were discharged an average of 1 day earlier than patients with a
primary LOC of chance, trust in self, or trust in others. Individuals with a balanced health
LOC had no extreme differences among health beliefs of chance, trust in self, and trust in
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others (Primavera & Kaiser, 1993). Lake et al. (2009) found that Medication Overuse
Headache, particularly from simple analgesics or triptans, was associated with significant
improvement at discharge from inpatient treatment. Patients least likely to benefit from
inpatient treatment were those with personality disorders, without Medication Overuse
Headache (Lake et al., 2009). Inpatients with opioid dependency, which was more
common among patients with Borderline Personality Disorder (BPD), had a longer LOS
than the average stay of 13 days. Lake et al.’s (2009) inpatient treatment included
medical intervention, cognitive-behavioral therapy (CBT), family therapy, relaxation, and
psychoeducational groups. The majority of the inpatient study population was diagnosed
with Chronic Daily Headache. Of the study population, 60% were diagnosed with Cluster
B personality disorders. While Lake et al. (2009) acknowledged that their study was
neither controlled nor randomized, they retorted that their inpatient population consisted
of treatment failures, some from respected experts in headache management.
Lake, Saper and Hamel (2009) described several theories for the relationships
among negative treatment outcome, BPD, and opioid dependence. One theory is that
patients with pain and BPD may be more attentive to internally induced pain, rather than
external pain. Another theory is that patients with pain have deficits in their ability to
regulate and tolerate distress in order to prevent escalation. Additionally, patients with
BPD have doctor-patient relationships that are difficult to manage, which may negatively
affect treatment outcome. Several hypothesized factors may explain the increased rates of
opioid dependence in inpatients with BPD. Physicians may be more likely to administer
opioids to patients with BPD because of the patient’s demanding, insistent interactions

LOS AND INPATIENT HEADACHE UNIT

51

with physicians. Likewise, patients with BPD may be more likely to request opioids as a
result of a dysregulation in their pain and affective systems, general emotional distress, a
need to control relationships, and beliefs of entitlement. Lake et al. (2009) proposed that
the relationship among the presence of BPD, opioid Medication Overuse Headache, and
negative outcome in their study may be related to the frequency of substance-abuse
disorders in individuals with BPD. Specifically, opioids not only may trigger Medication
Overuse Headache but also may exacerbate psychological symptoms, such as flashbacks,
dissociation, a feeling of emptiness, and self-injurious behaviors.
Few studies have been conducted regarding the relationships between inpatient
treatment outcome and scales as measured on the MMPI-2 and the Millon Behavioral
Medicine Diagnostic (MBMD) (Diaz, 2004; Grazzi et al., 2002). In a study conducted in
an inpatient setting with patients with chronic headache, MMPI-2 scales 2, 7, and 8
predicted LOS (Diaz, 2004). Particularly, scale 8, which measures confusion,
disorganization, poor judgment, anxiety, and pessimism, predicted a longer LOS.
Individuals scoring high on scale 8 may lack basic information to problem solve, and
they may feel socially and emotionally alienated (Butcher et al., 2001; Diaz, 2004).
Interestingly, individuals with elevations on scale 7 tended to have a shorter LOS (Diaz,
2004). Scale 7 measures anxiety, tension, insecurity, sadness, pessimism, and fatigue.
Individuals with elevations on scale 7 also may be meticulous and organized (Butcher et
al., 2001; Diaz, 2004). They also may worry about social acceptance or have difficulty
coping with stress (Diaz, 2004). Scale 2, measuring depression, hopelessness, and
insecurity, also predicted a longer LOS (Diaz, 2004). Individuals scoring high on scale 2

LOS AND INPATIENT HEADACHE UNIT

52

may be indecisive, lack self-confidence, or give up easily. Grazzi et al. (2002) found that
scale 1, which measures concern with physical and bodily complaints, cynicism, and
pessimism, predicted a negative outcome. Grazzi et al. (2002) reported that findings for
scales F, 6, and 8 have been difficult to interpret. Diaz (2004) found that the forceful
scale on the MBMD predicted a longer LOS (Diaz, 2004). Individuals scoring high on the
forceful scale tend to be domineering, stubborn, and suspicious when interacting with
others (Diaz, 2004). They also seek out challenges and are often risk-takers.
Headache Treatments
Medical
Headache disorders are treated in a variety of settings: outpatient headache
centers, inpatient headache units, and emergency departments (Kwiatkowski &
Alagappan, 2006). According to Kwiatkowski and Alagappan (2006), headache treatment
in an emergency department may be successful but is often costly and frustrating for
patients. Outpatient treatment can include medication therapy, nerve blocks, botulinum
toxins, and nerve blocks (Kwiatkowski & Alagappan, 2006). Inpatient treatment can
involve any of the previously listed outpatient treatments, along with intravenous therapy
to break the pain cycle (Kwiatkowski & Alagappan, 2006; Saper, 2008). Inpatient
therapy is reserved for intractable, severe, or complicated headache disorders
(Kwiatkowski & Alagappan, 2006; Saper, 2008).
Preliminary treatment of headache disorders usually involves abortive and
preventative medication therapy in an outpatient setting (Kwiatkowski & Alagappan,
2006). Abortive medications are used to limit the intensity and duration of an attack. For
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mild to moderate attacks, abortives, such as acetaminophen, aspirin, ibuprofen, naproxen
sodium, and tolfenamic acid, are suggested. For moderate to severe attacks, abortives,
including dihydroergotamine, triptans, prochlorperazine, metoclopramide, ketorolac, and
meperidine are suggested, some of which are administered intravenously or
intramuscularly.
Preventative medications are used to decrease the intensity and frequency of
attacks (Kwiatkowski & Alagappan, 2006). Preventative medications are used when there
are more than two to three attacks a month, attacks last longer than 48 hours, or attacks
are severe or debilitating. Preventative medications are usually 55 - 65% effective but
have significant side effects. Therefore, when headaches decrease, tapering and
discontinuing the preventative medication is recommended. Preventative medications
include β-adrenergic blocking agents; calcium channel blockers; tricyclic antidepressants;
anticonvulsants, such as divalproex sodium and sodium valproate; monoamine oxidase
inhibitors; and methysergide.
Intractable, severe, or complicated headache disorders are best treated in an
inpatient setting (Kwiatkowski & Alagappan, 2006; Saper, 2008). If aggressive outpatient
or emergency department treatment is not effective, inpatient treatment is recommended
(Saper, 2008). Specifically, inpatient treatment is necessary when detoxification is
needed, when the presence of comorbid medical or psychological disorders interferes
with treatment efficacy, or when unstable vital signs or dehydration is present (Saper,
2008). If not already completed, the preliminary steps of inpatient treatment involve
laboratory and imaging tests to rule out headaches caused by secondary conditions
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(Saper, 2008). Next, patients are given intravenous fluids and medications to break the
pain cycle (Saper, 2008). If present, Medication Overuse Headache is treated by
reduction of the overused drug while controlling withdrawal symptoms (Saper, 2008).
Psychological assessment is offered early during inpatient treatment, followed by
corresponding psychological treatment (Saper, 2008). Preventative and abortive
medications may be tried experimentally with in order to establish an outpatient regimen
offering more headache control (Saper, 2008).
Psychological
Psychological treatments for headache can influence the course and outcome of
headache disorders (Sheftell & Atlas, 2002). Psychological treatments complement the
efficacy of pharmacological treatments (Sheftell & Atlas, 2002). Treatments include
emotional disclosure, CBT, for stress management, relaxation, biofeedback, and patient
education.
Emotional disclosure. The negative effects of emotional inhibition on physical
symptoms have led to the development of therapeutic interventions to increase emotional
awareness (Keefe et al., 2001). For example, Keefe et al. (2001) described a treatment
used to increase awareness of emotions and the relationship between physical symptoms
and emotions. While the treatment has not been tested in controlled treatment outcome
studies, according to Keefe et al. (2001), one study found that participants showed a
reduction in symptoms (less temporomandibular joint pain or low back pain) and a
greater awareness of emotions.
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Emotional disclosure has varying outcomes, both positive and negative (Keefe et
al., 2001). Treatment during which intense emotion was elicited with gestalt techniques
reduced symptoms of depression but did not reduce long-term pain (Keefe et al., 2001).
While pain levels were lower after sessions, the average pain level of patients increased
between sessions (Keefe et al., 2001). Another approach that may be better suited for
patients with pain is disclosure of troubling emotions at the patient’s own pace (Keefe et
al., 2001). Patients can be encouraged to write about stressful experiences in a selfdirected and self-paced manner in order to avoid symptom exacerbation (Keefe et al.,
2001). Overall, according to Keefe et al. (2001), emotional disclosure seems to result in
short-term distress but long-term improvement taking several months.
Emotional disclosure has shown mostly positive effects for patients with
rheumatoid arthritis (Keefe et al., 2001). Keefe et al. (2001) described one study that
found that patients with rheumatoid arthritis reported significantly less affective
disturbance and improved ability to conduct daily activities after 3 months of disclosure
about stressful experiences. Although patients reported increased negative mood after
verbal disclosure, they had the most improvement in their joint condition after 3 months
as determined by a physician examination and physical tests. Patients with rheumatoid
arthritis participating in emotional disclosure also had objective health improvements.
Patients who wrote for 3 days about stressful experiences had significantly lower global
impairment scores after 4 months as compared to those of controls, as assessed by
physicians who were blind to groups.
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According to Keefe et al. (2001), patients with rheumatoid arthritis are not the
only individuals who can benefit from emotional disclosure. College students and healthy
people in the community experienced health benefits by expressing emotions through
private writing or verbal disclosure. Decreased health-care visits, enhanced
immunological response, improved grade-point average, and faster reemployment after
being laid off were some positive benefits. Emotional disclosure also may help
individuals who catastrophize about dental procedures. Patients who participated in
emotional disclosure and scored high on catastrophizing reported less pain and better
mood than participants who scored high on catastrophizing and were in the control group.
Along with the emotional component of emotional disclosure, physiological and
cognitive mechanisms are involved (Keefe et al., 2001). Venting emotions may decrease
pain by changing the physiology that contributes to pain. Keefe et al. (2001) proposed
that emotional processing activates the emotional schema, leading to cognitive changes.
Emotional disclosure creates disconfirming evidence when negative affective states do
not lead to harm. Additionally, repeated disclosure creates habituation to negative
affective states. However, emotional catharsis in itself, without cognitive change, seems
to be counterproductive.
CBT. CBT can help patients with headache cope better with everyday stresses that
may trigger, exacerbate, or maintain headaches (Penzien et al., 2005). CBT helps patients
identify cognitive and affective components of the stress response and understand the
relationship among headaches, stress, and coping ability. Patients are guided to find the
cognitive, emotive, and behavioral triggers of headaches and use more effective strategies
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to deal with headache-related stress. For example, patients often respond to a debilitating
headache condition with depression or anxiety, which CBT can reduce. CBT is used
often in conjunction with relaxation techniques and biofeedback.
More specifically, CBT can be helpful for psychological problems, such as low
self-efficacy, low internal LOC, or anxiety that can make managing headaches difficult
(Nicholson et al., 2007). Patients may think they have no influence on headache attacks
(low internal LOC) or that they are not able to manage headache triggers (low selfefficacy). Educating patients about ways to manage headache triggers to reduce the
number of headache attacks and about their role in managing triggers can increase
internal LOC. In addition, socratic questioning can be helpful for patients with anxietyrelated disability who have catastrophic fears. For example, therapists can guide patients
who limit their activity because of fear of provoking a headache to find instances when
activity did not result in debilitating headaches or when medications aborted the
headache.
Relaxation and biofeedback. Relaxation techniques and biofeedback involve the
practice of controlling physiological responses that contribute to headaches (Penzien et
al., 2005). Relaxation training and biofeedback can help patients gain better control over
headache-related physiology in general by lowering sympathetic arousal. Relaxation is
taught as a headache preventative, not an abortive. Practice is emphasized before seeing
results, as training may take as many as 10 sessions. Three types of relaxation training are
widely used—progressive muscle relaxation, autogenic training, and mindfulness.
Progressive muscle relaxation involves alternating between tensing and relaxing muscles;
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autogenic training involves using heaviness and warmth; and mindfulness involves
calming the mind by maintaining focus on repeating words.
Biofeedback is the practice of controlling physiological responses, such as skin
temperature and muscle tension (Penzien et al., 2005). Patients are taught to warm finger
temperature and/or reduce arousal and muscle tension (Penzien et al., 2005). They are
provided feedback on their performance through sensors that detect their physiological
responses (Holroyd et al., 1984). Relaxation is usually a main component of biofeedback
(Penzien et al., 2005). Like relaxation training, biofeedback is a preventative treatment
that must be practiced at home regularly to be effective (Penzien et al., 2005).
Outcomes of relaxation and biofeedback practice vary, depending on the research
(Freitag et al., 2004; Grazzi et al., 2002; Holroyd et al., 1984; Hoodin et al., 2000).
According to Holroyd et al. (1984), successful performance feedback was associated with
headache reduction. Holroyd et al. (1984) proposed that successful performance feedback
leads to cognitive changes in self-efficacy and LOC, which are both associated with
headache reductions. Freitag et al. (2004) reported that patients who practiced relaxation
more frequently during severe headaches and to prevent headaches showed the greatest
decrease on the Beck Depression Inventory (BDI) at discharge during inpatient treatment.
The change in BDI scores was correlated with the frequency of relaxation practice
(Freitag et al., 2004). However, there was no significant correlation between BDI changes
and reduction of severe headache. Grazzi et al. (2002) reported that during inpatient
treatment, patients who received biofeedback and relaxation training in conjunction with
pharmacologic intervention experienced a clear advantage from treatment over a 3 year
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period, as compared to patients receiving only pharmacologic intervention. Levels of
improvement for the combined treatment group remained the same at posttreatment
(Grazzi et al., 2002). Likewise, the relapse rate was significantly lower in the combined
group at 3 years (Grazzi et al., 2002). Patients receiving the combined group treatment
were also more careful in their use of analgesic medications (Grazzi et al., 2002).
According to Hoodin et al. (2000), the practice of relaxation during inpatient medical
intervention was associated with decreased depression as measured by BDI scores.
Hoodin et al. (2000) proposed that an internal health LOC may have contributed to the
increased adherence to relaxation practice and that treatment gains may have contributed
to the decrease in depression.
Patient education. Patient education can help patients to manage headache
episodes, become independent with self-care, initiate activities to manage headaches,
manage medical therapies better, and alter daily routines to manage headaches (Sheftell
& Atlas, 2002). Education should help patients understand how the underlying biology of
the headache disorder is influenced by triggers, such as diet, hormones, environmental
changes, sensory stimuli, and stress (Sheftell & Atlas, 2002). Likewise, teaching patients
about the functions of abortive and preventative medications can help patients become
more involved in their treatment plan (Sheftell & Atlas, 2002). Patient education can be
used to improve medication compliance, especially for patients who have low selfefficacy for taking medication (Nicholson et al., 2007). Providers should discuss barriers
to adherence and give reinforcement for adherence in order to increase self-efficacy and
medication compliance (Nicholson et al., 2007).
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Chapter Three: Hypotheses
The purpose of this study is to predict a longer LOS and minimal improvement by
regressing LOS and minimal improvement on a number of psychological variables as
measured on the MBMD (Millon, Antoni, Millon, Minor, & Grossman, 2006). LOS is
measured by the difference between the admission and discharge dates. Both the
admission and discharge dates are included in the calculation of the LOS. Minimal
improvement is measured by the difference between admission and discharge scores on
the Brief Pain Inventory-Short Form (BPI-SF; Cleeland, 2009) interference and severity
scales and the difference between preadmission headache index scores and discharge
headache index scores. The headache index score assesses frequency, duration, and
severity of headaches.
Hypothesis 1
Ho: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual
absence) does not significantly and independently predict a longer LOS.
H1: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual
absence) significantly and independently predicts a longer LOS.
Hypothesis 2
Ho: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual
absence) does not significantly and independently predict minimal improvement.

LOS AND INPATIENT HEADACHE UNIT

61

H2: A combination of variables on the MBMD (i.e., anxiety-tension, depression, a
forceful coping style, pain sensitization, social isolation, future pessimism, and spiritual
absence) significantly and independently predicts minimal improvement.
Hypothesis 3
Ho: After inpatient treatment, there was not a significant difference between
admission and discharge BPI-SF interference scores.
H3: After inpatient treatment, there was a significant difference between
admission and discharge BPI-SF interference scores.
Hypothesis 4
Ho: After inpatient treatment, there was not a significant difference between
admission and discharge BPI-SF severity scores.
H4: After inpatient treatment, there was a significant difference between
admission and discharge BPI-SF severity scores.
Rationale
Psychological factors, such as depression, anxiety, personality traits, and
maladaptive coping skills, can complicate headache disorders. Individuals with comorbid
depression experienced more disability from migraine headaches than individuals without
comorbid depression (Breslau et al., 2003). Likewise, depression is a risk factor for
increasing the likelihood of the onset of pain and/or the exacerbation of pain (Keefe et al.,
2001). With medical conditions in general, depression and dysphoria are obstacles for
some patients attempting to adapt to lifestyle changes, recover from procedures, and
adhere to medication regimens (Cruess et al., 2007). According to Nash et al. (2006),
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patients with headache and increased anxiety have more disability, a poorer quality of
life, and higher health-care costs than those without increased anxiety. Pain sensitization
causes misdirected attempts to escape or avoid pain, which reinforces negative emotions,
resulting in functional disability (Janssen, 2002). Social isolation predicted greater pain
and psychological dysfunction in patients with fibromyalgia (Zautra et al., 1999).
According to Ferreira and Sherman (2007), there are relationships between improved
psychosocial and physical-health outcomes and optimism. Rippentrop (2005) found that
spirituality was an independent predictor of positive affect in a sample of patients with
rheumatoid arthritis. This author is assuming that the psychological factors discussed in
the literature review that complicate the headache disorder will lead to a longer LOS
and/or minimal improvement. Likewise, discovering whether this study replicates the
results found by Diaz (2004), that the forceful scale on the MBMD predicted a longer
LOS, would be beneficial.
Hypotheses 3 and 4 regarding the efficacy of inpatient treatment as measured by
the BPI-SF were proposed in order to confirm minimal improvement as a valid, accurate
construct in reference to the inpatient treatment provided. For example, if inpatient
treatment was not effective for the majority of inpatients, the ability of the proposed
psychological variables to predict minimal improvement would be skewed. However, the
efficacy of inpatient treatment was not the focus of this study. Therefore, experimental
controls were not implemented for treatment-efficacy hypotheses.
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Chapter Four: Methods
This quasi-experimental, prospective, cross-sectional, survey research study used
multiple regression to predict psychological factors associated with a longer LOS and
minimal improvement in a headache inpatient unit. Survey research is the most efficient
way to collect data for this study. It is the least obstructive and time-consuming method
for patients. Collecting data prospectively avoided recall errors that patients may have
had if they had been required to rely on their memory.
Study Overview
This study was conducted at the Jefferson Headache Center at Methodist Hospital
between the months of August 2010 and May 2011. The headache inpatient unit at
Methodist Hospital practices an interdisciplinary-team approach composed of attending
physicians, the nurse coordinator, a headache fellow, a neurology resident, a
psychologist, a psychiatrist, unit nurses, and a physician assistant, all of whom coordinate
care. As a standard of care, patients must have a neurological evaluation before
admission to rule out causes of pain other than headache. All patients are diagnosed with
a headache condition within the standards of the International Headache Society before
admission. As a part of the inpatient admission process, patients are required to complete
a calendar to record their headache frequency, severity, and duration for at least 1 week
before planned admission.
Assuming two-tailed α = 0.05 and power = 0.95, a sample of 153 patients would
allow a determination of whether the seven hypothesized psychological factors predict
minimal treatment outcome and a longer LOS (Faul, Erdfelder, Buchner, & Lang, 2009).
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The headache center at Methodist averages 10-13 inpatients a week. Recruitment was
estimated to take approximately 4 to 8 months. However, glitches with recruitment
precluded following the planned schedule. From August 2010 through October 2010, key
personnel tried to increase the response rate of the preadmission calendars used to obtain
baseline headache index scores. At the start of collecting data in August, key personnel
realized that calendars were not being included in the inpatient packets mailed to patients
prior to planned admissions. Likewise, about half of inpatients were admitted on an
emergency basis, precluding the possibility of completing the preadmission calendar
during the week before admission. As a result, staff circulated calendars, encouraging all
patients to complete a calendar on a daily basis and to bring the calendar when admitted
for inpatient treatment. Data collection resumed in November despite the continued poor
response rate of preadmission calendars. Study procedures were not changed as a result
of the poor response rate because reliable outcome measures, such as LOS and BPI-SF,
were being collected as well. Preadmission calendars continued to be collected from
participants who had them. Consenting inpatients were included regardless of whether
they had the preadmission calendar.
Data collection outcome
By the end of May 2011, there was a total of 87 consenting participants.
Approximately two to four inpatients consented to the study each week. Several factors
could have attributed to the difficulty of amassing consenting participants in the numbers
as estimated. Many patients were sleeping or in pain during the consenting opportunities.
Additionally, some patients declined because they had visitors at the time. Some patients
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declined because they reported that they did not have the cognitive ability to complete the
surveys. There were 36 participants who did not complete the discharge BPI-SF for
several reasons. Some patients did not complete the discharge BPI-SF because they
refused or did not stay for the entirety of treatment as recommended. However, a majority
of the discharge BPI-SF forms were not completed because of communication issues
between key personnel and headache center inpatient staff.
Inclusion criteria
Patients admitted into the headache inpatient unit between November 2010 and
May 2011 were approached with opportunities to consent to being a participant in the
study. Participants were 18 years or older. Individuals younger than the age of 18 years
are not admitted into this inpatient unit. In order to be included in the study, patients were
required to have had the headache disorder for 3 or more months, demonstrate the ability
to consent, complete measures at admission and discharge, and complete the entire stay
as recommended.
Exclusion criteria
Patients with the following characteristics were excluded from the study: patients
who had a cluster headache disorder, did not speak and read English, were not able to
consent, failed to complete measures at both admission and discharge, left early against
recommendations because of insurance or personal reasons, and did not have the
headache disorder for 3 or more months.
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Consent process
Key personnel visited new patients no longer than 1 day after admission and
asked several questions in order to assess the patients’ ability to consent. Patients were
asked questions to determine whether they spoke and read English and were oriented to
date, time, place, and persons. Patients were visited again at a later date if they were
unable to consent because of sleep, fatigue, and/or disorientation during the initial
attempt.
Upon meeting initial inclusion criteria of speaking English and having the ability
to consent, key personnel briefly explained the purpose of the study and the consent
process to patients. Key personnel reviewed the risks and benefits and emphasized that
participation was voluntary, did not affect care, and could be withdrawn at any time
without any consequences. Patients were given as much time as needed to read the
informed consent, ask questions about the study, and consent or decline. After providing
written informed consent, key personnel reviewed patients’ records to ensure that they
met the additional inclusion criteria (having the headache disorder for 3 or more months,
no cluster headache diagnosis) and ensured that the patient planned to stay for the entirety
of treatment. Patients who did not meet inclusion criteria were notified of the reason they
could not participate. A copy of the informed consent was kept in a separate file for
patients who qualified. The consent forms for those who did not qualify were shredded.
Procedures
Key personnel gave patients who consented and met inclusion criteria a copy of
their signed informed consent, the MBMD, the BPI-SF, the calendar to complete during
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the stay, and a demographic profile created for this study. The demographic questionnaire
included questions about age, gender, race, education level, and work status. The
admission measures typically took 60 minutes to complete. While patients had as long as
90 minutes to complete the measures, arrangements were made to accommodate patients
who needed more time. Key personnel picked up the measures after 90 minutes or at a
later date if more time was needed. No sooner than 1 day before discharge, patients were
given the BPI-SF again, which typically took 5 minutes to complete.
After completion of admission and discharge measures, the patient’s name, dates
of admission and discharge, LOS, and medical and psychiatric diagnoses were recorded
on a form labeled, “Patient Information.” Medical and psychiatric diagnoses were
obtained from the current inpatient hospital records and recorded on the Patient
Information form. Additional survey data (MBMD, admission and discharge BPI-SF,
preadmission and discharge headache index score) were matched with the patient
information data and entered on a spreadsheet. The spreadsheet file was password
protected. Upon completion of the study, the file was deleted and survey data were
shredded. Until completion of the study, survey data were secured in a locked filing
cabinet kept on site. While names were collected, they were neither reported nor
published.
Measures
MBMD. The MBMD (Millon et al., 2006) is a self-report measure developed to
reflect the attitudes, behaviors, and concerns of medical patients. It measures factors such
as psychiatric indicators, coping styles, stress moderators, treatment prognostics, and
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management guides (Cruess et al., 2007). Three scales, Debasement, Desirability, and
Disclosure, are designed to correct for response patterns that may distort scores (Cruess et
al., 2007). The measure includes 165 true-false items, estimated to take approximately
20-25 minutes to complete (Cruess et al., 2007). The MBMD was normed on more than
700 patients, from the age range of 18 to 85 years, with medical conditions, such as heart
disease, cancer, diabetes, chronic pain, and HIV/AIDS (Cruess et al., 2007). The MBMD
demonstrates both internal reliability and consistency, with an internal consistency
coefficient mean of α = .79 for all scales and a test-retest reliability mean of .83 for all
scales (Cruess et al., 2007). With convergent validity, the MBMD depression scale
correlated at .87 with the BDI. Prevalence scores reflect a comparison to the normed
population (Cruess et al., 2007). Of the coping styles, a prevalence score of 60 or higher
should be considered in analyses (Millon et al., 2006). Of the psychiatric indicators, a
prevalence score of 75 - 84 suggests the presence of the scale’s disorder, while a
prevalence score of 85 and higher suggests a prominence of the scale’s disorder (Millon
et al., 2006). Prevalence scores between 60 and 74 are suggestive of the presence of
symptom pathology but not sufficiently indicative unless the score is the highest score of
the psychiatric indicators (Millon et al., 2006).
For this study, the scales analyzed will be a) anxiety-tension and depression from
the psychiatric indicators, b) forceful coping style, and c) pain sensitization, social
isolation, future pessimism, and spiritual absence from the stress moderator scales. For all
categories of scales, this study included scores of 60 or higher in analyses. Items on the
anxiety-tension scale include “I’m on edge a lot lately” and “I feel jumpy and under
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strain, but I don’t know why” (Millon et al., 2006). The depression scale measures poor
appetite, social withdrawal, discouragement, guilt, behavioral apathy, self-depreciation,
and anhedonia. The forceful scale measures domineering, tough-minded, and distrustful
characteristics. The pain sensitization scale measures the tendency to be overly sensitive
and reactive to pain. The social isolation scale measures perception of social support. The
future pessimism scale measures outlook towards health status. The spiritual absence
scale measures spiritual or religious resources to cope with stress, fear, or uncertainties
associated with medical conditions.
Headache index score. The headache index score measures headache frequency,
duration, and severity. A calendar with an intensity scale will obtain frequency, duration,
and severity of headaches. The headache index score was calculated by multiplying each
day’s average intensity, by duration of headache in hours for that day, adding the week’s
total multiplications of hours and intensity, and dividing by the total number of days.
Intensity is measured on a scale from 0 (no pain) to 10 (the worst pain you can imagine).
Outcome was determined by the difference between preadmission and discharge
headache index scores. The higher the difference, the better the outcome. Zero indicated
no change from treatment. A negative difference indicated a regression from the
admission condition.
BPI-SF. The BPI-SF is a widely used self-report measure to assess clinical pain
(Cleeland, 2009). The BPI-SF is composed of two factors: severity and interference. The
interference factor has two subdimensions, an affective subdimension and an activity
subdimension. The affective subdimension measures pain interference in reference to
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relationships, enjoyment of life, and mood. The activity subdimension measures pain
interference in reference to walking, general activity, and work. A five-option verbal
descriptor scale, with ratings of 0 = not at all, 1 = a little bit, 2 = moderately, 3 = quite a
bit, and 4 = extremely, is used to measure pain interference. Pain severity is assessed by
asking questions about pain over time: at its “worst,” “least,” “average,” and “now.” The
recall period of the severity and interference scale is a week. A numerical rating scale is
used to measure pain severity, where 0 = no pain and 10 = worst pain you can imagine.
For this study, outcome was determined by the differences between admission and
discharge interference and severity scores. The higher the difference, the better the
outcome. Zero indicates no change from treatment. A negative difference indicates a
regression from the admission condition.
Factor analysis in a large outpatient metastatic cancer study (N = 1,261) verified
the two separate factors of pain severity and interference. In the same study, internal
stability was good, ranging from .80 to .87 for the four pain severity items and .89 to .92
for the seven interference items. Multidimensional scaling provided strong psychometric
support for the independent measurement of pain interference and severity. Initial shortterm (1 day to 1 week) test-retest reliability for ratings of “worst,” and “average,” pain
severity was acceptable (.78). Test-retest reliability for pain “now” is less (.59). Several
more recent studies found similar test-retest coefficients. An outpatient German pain
clinic study with retest occurring 30-60 minutes after the first administration found
coefficients of .98 for pain severity and .97 for pain interference. Reliability coefficients
for daily administration of pain severity “worst” “average” and “current” ranged from .83
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to .88. Test-retest reliabilities for pain interference in the same study ranged from .83 to
.93.
Analysis of Risk and Benefits
While patients in the study will not directly benefit from participation, the study
may help future patients by providing data potentially to implement programs and/or
procedures aimed to ameliorate factors associated with a longer LOS and minimal
improvement. New programs and/or procedures aimed at specialized care could lower
costs incurred by headache both to patients and society. There is a rare risk that patients
may experience psychological distress from completing the measures. In the case that
patients experience distress, psychological support is available on the unit to remediate
the situation.
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Chapter Five: Results
Data Collection Outcome
The difference between preadmission and discharge headache index scores was
not used as a criterion variable because of the low response rate of the preadmission
calendar. The response rate for the preadmission calendar used to obtain baseline
headache index scores was only 6.9% among consenting participants. Of the 87
consenting participants, 36 were lost owing to failure to obtain discharge data, leaving a
total of 51 completed protocols (see Table 1 for specific demographic information of
consenting participants). Of the sample population, 78% was age 35 years and older. For
analyses purposes, adults aged 18 to 34 years and adults aged 35 years and older were
coded into two separate categories.

Table 1
Demographics of Consenting Participants
Gender

Hispanic

African American

Caucasian

Female

3

4

71

Male

0

1

8
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Analyses and Results for Hypotheses 1 and 2
A multiple linear regression analysis was performed to determine the proportion
of variance accounted for by the model, the significance of the model, and the
significance of the predictor variables to predict the criterion variables (LOS and minimal
improvement as measured by BPI-SF interference and severity differences scores). The
model included the following scales: anxiety-tension, depression, forceful coping style,
pain sensitization, social isolation, future pessimism, and spiritual absence. Using the
simultaneous “enter” method on SPSS, version 19.0, all seven predictor variables in the
model were entered in three separate analyses for each criterion variable. The proportion
of the variance accounted for by the hypothesized model to predict each criterion variable
(LOS and minimal improvement as measured by BPI-SF interference and severity
difference scores) was not significant (see Table 2). Specifically, hypothesis 1, stating

Table 2
Significance of Hypothesized Model to Predict LOS and Minimal Improvement
Dependent Variables

R Square

F

Adjusted R

LOS

.034

.219

-.123

Severity

.089

.601

-.059

Interference

.170

1.256

.035

Note. Model 1 predictors: Pain Sensitization, Depression, Anxiety, Social Isolation, Spiritual Absence,
Pessimism, Forceful Coping Style. Severity and Interference scores are measured by the Brief Pain
Inventory (Short Form). LOS= length of stay.
p < .05.
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that the model predicted a longer LOS, was not supported. Hypothesis 2, stating that the
model predicted minimal improvement also was not supported. Additionally, there were
no significant correlations between individual predictors of the model and each criterion
variable.
Exploratory Analyses and Results
As observed during data review, a majority of the sample had elevations on the
Pessimism and Pain Sensitization scales (see Table 3). Likewise, a pattern emerged
among the refractory cases. A case was determined refractory when there was a LOS of 8
days or longer and BPI-SF interference or severity scores were less than or equal to 1.5.
The refractory criteria were determined based on review of the outcome means (see Table
4 for means and standard deviations of outcome variables). Nonmarried participants with
low Confident and Sociable scores and a high Denigrated score on the MBMD coping
skills scales were observed to have minimal improvement after inpatient treatment in this
sample population (see Table 5 for sample percentages of elevations and absences of
elevations of exploratory variables). Marital status was coded as either married or not
married. Participants labeled single, divorced, or separated were coded as not married for
analyses purposes. Supplemental analyses were conducted using two exploratory models
based on the aforementioned findings. Predictors of the first exploratory model included
marital status and denigrated coping style. Predictors of the second exploratory model
included sociable and confident coping styles. Only two predictors were included in each
exploratory model because of the small sample size in order to increase the chances of
detecting significance. Using the simultaneous “enter” method on SPSS, version 19.0,
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predictor variables in the models were entered in three separate analyses for each
criterion variable. The proportions of variance accounted for by the exploratory models

Table 3
Percentages of Inpatients with Elevations on Predictor Variables
Forceful
coping
style
8

Depression

69

Pain
Anxiety
sensitization
94

59

Spiritual
absence

Social
isolation

Pessimism

31

37

84

Note. n = 51. Decimals rounded to whole numbers. Prevalence score ≥ 60.

Table 4
Mean and Standard Deviation of LOS, BPI-SF Severity, and Interference Difference
Scores
Dependent Variables

Mean

Standard deviation

LOS

7.29

2.11

BPI-SF interference score

3.29

2.75

BPI-SF severity score

3.39

2.26

Note. n = 51. Decimals rounded to tens place. LOS = length of stay; BPI-SF = Brief Pain Inventory (Short
Form).
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Table 5
Percentages of Inpatients with Elevations and Absences of Elevations on Exploratory
Predictors in Supplemental Analyses
Denigrated

Sociable

Confident

Not married

63

63

69

39

Note. n = 51. Denigrated, Sociable, and Confident are coping skills scales on the Millon Behavioral
Medicine Diagnostic. Decimals rounded to whole numbers. Sociable and Confident scales percentages
represent an absence of elevation.

to predict each criterion variable (LOS and minimal improvement as measured by BPI-SF
interference and severity difference scores) were not significant (see Tables 6 and 7).
Owing to the high percentage of older adults in the population sample,
exploratory analyses were conducted on the disabled status collected on the demographic
questionnaire and the outcome variables. Participants had the following options on the
demographic questionnaire regarding work status: employed part-time or full-time,
student, unemployed, or disabled. For analyses purposes, disabled status was coded into
two categories, disabled and not disabled. Any category other than disabled was
considered not disabled. On the demographic questionnaire, the disabled category did not
specify whether someone was receiving public assistance. A Pearsons r bivariate
correlation was conducted using SPSS, version 19.0, to determine correlation between the
disabled category and each outcome variable (LOS and minimal improvement as
measured by BPI-SF interference and severity difference scores). There were no
correlations between the disabled category and the outcome variables (see Table 8).
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Table 6
Significance of Exploratory Model of Marital Status and Denigrated Coping Style to
Predict LOS and Minimal improvement
Dependent
Variables
LOS

R Square

F

Adjusted R

.231

1.348

.014

Severity

.093

.208

-.033

Interference

.077

.143

-.036

Note. Exploratory model predictors: Married Marital Status and Denigrated Coping Style. Severity and
Interference scores are measured by the Brief Pain Inventory Short - Form. LOS = length of stay.
p < .05.

Table 7
Significance of Exploratory Model of Sociable and Confident Coping Styles to Predict
LOS and Minimal Improvement
Dependent
Variables
LOS

R Square

F

Adjusted R

.024

.578

-.017

Severity

.097

.230

-.032

Interference

.015

.376

-.026

Note. Exploratory model predictors: Sociable and Confident Coping Styles. Severity and Interference
scores are measured by the Brief Pain Inventory Short - Form. LOS = length of stay.
p < .05.
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Table 8
Correlations Between Disabled Category and Outcome Variables
Dependent Variables

Pearson correlation

Significance

LOS

-.026

.428

Severity

-.153

.141

Interference

-.071

.311

Note. Severity and Interference scores are measured by the Brief Pain Inventory Short - Form. LOS =
length of stay. n = 51. Significance = 1-tailed.

Analyses and Results for Hypotheses 3 and 4
For analysis of the third and fourth hypotheses, a dependent, paired-samples t-test
using SPSS, version 19.0, was performed to determine the efficacy of inpatient treatment
by comparing the difference between admission and discharge BPI-SF interference and
severity scores. The mean admission BPI-SF interference score (M = 6.0188),
significantly exceeded the discharge BPI-SF interference score (M = 2.7316), t(50) =
8.545, p = .000. After inpatient treatment, the difference between BPI-SF interference
admission and discharge scores was a little larger than one standard deviation (d =
1.1963). The third hypothesis, stating that after inpatient treatment there was a significant
difference between admission and discharge BPI-SF interference scores, was supported.
Therefore, after inpatient treatment, interference of headaches during daily activities was
significantly reduced. The mean admission BPI-SF severity score (M = 6.00),
significantly exceeded the discharge BPI-SF severity score (M = 2.6373), t(50) = 10.765,
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p = .000. After inpatient treatment, the difference between BPI-SF severity admission and
discharge scores was a little larger than one standard deviation (d = 1.5112). The fourth
hypothesis, stating after inpatient treatment there was a significant difference between
admission and discharge BPI-SF severity scores, was supported. Therefore, after
inpatient treatment there was a significant reduction in severity of headaches.
Additionally, 59% of the sample obtained a score of 0 or 1 at discharge on the BPI-SF
severity item asking on a scale of 1-10 for a rating of current pain.
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Chapter Six: Discussion
Summary of Findings
In review, the first and second alternate hypotheses were not supported.
Specifically, the combination of psychological factors hypothesized (anxiety-tension,
depression, a forceful coping style, pain sensitization, social isolation, future pessimism,
and spiritual absence) did not predict a longer LOS or minimal improvement for this
sample of inpatients with headache. The third and fourth alternate hypotheses were
supported. Overall, inpatients in this sample experienced improvements in headache
severity and interference of functioning from headaches after inpatient treatment. The
confirmation of the third and fourth alternate hypotheses supports the contention that
minimal improvement was a valid, accurate construct used in this study. Inpatient
treatment efficacy was likely not a confounding variable conflicting with the ability of
hypothesized psychological variables to predict minimal improvement. Inpatient
treatment for this headache center may be an effective treatment option for patients with
difficult-to-treat headache disorders.
While reviewing data, a pattern was observed among refractory cases.
Nonmarried participants with low Confident and Sociable scores and a high Denigrated
score on the coping skills scales had minimal improvement after inpatient treatment in
this sample. Therefore, exploratory analyses were conducted, which were not supported.
Specifically, a nonmarried marital status in combination with a high Denigrated coping
skills score was not significant in predicting minimal improvement or a longer LOS.
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Likewise, low Confident and Sociable coping skills scores were not significant in
predicting minimal improvement or a longer LOS.
Significance of Findings
Support for the efficacy of inpatient treatment for headache at this headache
center was confirmed. While confirmatory research is needed, patients with difficult-totreat headache conditions should be considered for inpatient treatment. Depending on
future research on long-term outcomes of inpatient treatment, not only may inpatient
treatment be effective for difficult-to-treat headache disorders, but it also may be a more
cost-efficient option.
As observed during the data review, a majority of the sample had elevations on
the Pessimism and Pain Sensitization scales. Of the sample population, 94% had elevated
Pain Sensitization scores and 84% had elevated Pessimism scores. For this sample, Pain
Sensitization and Pessimism were likely not predictors of LOS and minimal
improvement. The prevalence of the elevations likely precluded the predictive ability of
those factors. Additionally, there were no significant correlations between Pessimism or
Pain Sensitization scores and the outcome variables. Pessimism and Pain Sensitization
may simply be factors characteristic of a difficult-to-treat headache disorder, rather than
predictors of treatment outcome.
The MBMD measure may be helpful in identifying patients who have or will have
a difficult-to-treat headache disorder that requires inpatient treatment. As mentioned
previously, Pain Sensitization and Pessimism scales may be indicators of a difficult-totreat headache disorder. A neurologist considering inpatient treatment for a patient could
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refer during the decision-making process to the MBMD to check the Pain Sensitization
and Pessimism scales. If the patient has elevations on these scales, he or she may have a
difficult-to-treat headache disorder requiring more intensive inpatient treatment.
There are several explanations for the unsupported first, second, and exploratory
hypotheses. There may be factors that do not complicate the headache disorder that
predict a longer LOS and minimal improvement. The logical conclusion that factors that
complicate headache disorders predict minimal improvement or a longer LOS may not
stand true. Commonplace factors, such as the schedule of the patient, the patient-doctor
relationship, and the schedule of the doctor, should be explored in future studies for their
ability to predict LOS and minimal improvement. Additionally, study limitations and the
potential for medical factors to hold more weight in predicting LOS and minimal
improvement are considerations for the unsupported hypotheses.
Findings Related to Literature Review
The sample demographics are important to consider in reference to the findings.
As discussed in the literature review, headache disorders influenced by psychological
comorbidity were more common for individuals in the 25 to 34 year age range (Bensenor
et al., 2003). This sample, composed of 78% of adults ages 35 years and older, may have
not had psychological comorbidity as a relevant factor in complicating the headache
disorder. With adults from ages 55 to 64 years, functional deficits, such as physical
limitations and lifestyle changes, influenced headache disorders (Bensenor et al., 2003).
If the logic is true behind the theory driving the first two alternative hypotheses, the
demographic characteristics of this sample may have precluded findings that could
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support hypotheses composed of psychological constructs. Future research with older
inpatient populations should explore functional deficits as predictors of treatment
outcome. Likewise, considering that the prevalence of comorbid medical disorders is
higher in an older adult population, future research should examine the types of medical
disorders, the severity of medical disorders, and the number of medical disorders as
predictors of minimal improvement and/or LOS.
Relevance of Findings to the Theory and Practice of CBT
When considering CBT’s value to patients who suffer from headache, the
function of psychological symptoms for patients with a headache disorder should be
considered. Anxiety and depression are considered maladaptive coping strategies.
However, anxiety and depression about the future is reasonable for someone with a
debilitating headache disorder, who has experienced many failed treatment attempts.
Perhaps anxiety and depression did not predict a negative outcome because, despite
complicating the headache disorder, they serve the function for the patient of staying
persistent with treatment efforts. For example, while thinking of better times can make
someone depressed, it also may reflect hope that improvement is possible. While
anticipating pain can make someone anxious, it also may reflect a desire to try to plan for
a future without pain. Hassinger et al. (1999) proposed similar theories. They stated that
pain may create a mobilization effect to use any coping strategy available, whether
adaptive or not (Hassinger et al., 1999). Additionally, they proposed that maladaptive
strategies may work for dealing with headaches but may not be effective when used in
other situations (Hassinger et al., 1999). Certainly, there are adaptive ways to cope with
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pain that exclude depression and anxiety. Encouraging optimistic thinking that reflects
small, achievable, incremental steps of improvement is best for patients with headache.
Findings Applicable to Future Research
As opposed to depression and anxiety, which, while maladaptive, could serve a
function of persistence with treatment, coping skills that function to maintain the
headache condition rather than to ameliorate it may be critical in predicting a negative
treatment outcome. A construct discussed in the literature review that may represent a
coping skill that maintains the headache condition is what Gatchel described as the “sick
role” (Dersh et al., 2002). Gatchel proposed that acute pain transforms into chronic pain
when the patient begins to habituate to aspects of the sick role. Patients habituate to the
sick role when they use the chronic condition as an excuse to avoid responsibility and
social obligations. Interestingly, Lucas et al. (2007) reported that a lack of response to
headache treatment was correlated with using acceptance as a coping strategy. In
response to the finding, Lucas et al. (2007) proposed that acceptance may reflect
helplessness, an unwillingness to take control of headaches, or a transition from seeking
treatment to adaptation to the disorder.
Suggestions for Future Research
Researching the coping skills that patients with headache use throughout the
progression of their headache disorder could be influential in determining the interaction
among coping skills, medical characteristics of the headache disorder, and treatment
outcome. Psychologists should collaborate with neurologists in order to identify stages in
the progression of the headache disorder as determined by medical characteristics that
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define the severity of the disorder. Neurologists also could define stages as they see fit
that appropriately define the progression of the headache condition.
Research also is needed to determine the coping skills that are specific to use by
patients with headache. While many coping skills are identified as used by patients with
pain and/or patients with functional impairments, these coping skills may or may not
generalize to patients with headache. One area of interest is the assimilative and
accommodative coping process as described by Rothermund and Brandtstädter (2003).
They reported the process of coping with functional impairments in aging adults as a
combination of assimilative and accommodative coping skills, used in conjunction with
available resources. They proposed that when assimilative coping skills were no longer
efficient to avoid losses of functional impairments, aging adults used accommodative
coping skills to change their personal standards. Patients with headache may parallel this
coping process. In the beginning of the headache disorder, patients may use assimilative
coping skills, gathering all their resources and putting all their effort into avoiding losses
associated with the headache condition. However, after many failed treatment efforts,
patients with headache may change their personal standards to reflect acceptance of the
headache disorder. While Rothermund and Brandtstädter (2003) proposed that
accommodative coping strategies serve as a buffer, Lucas et al. (2007) proposed that
acceptance may reflect a negative process involving helplessness.
Tracking coping skills used by patients with during the progression of their
headache disorder is preliminary in nature. Therefore, a case study design with only a few
participants would be appropriate. The focus would be on determining the interaction
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between the stages of the headache disorder and the function of the coping skills used.
Finding valid, reliable measures of coping skills can help to determine predictors of
negative treatment outcome. As mentioned previously, commonplace factors, such as the
schedule of the patient, the patient-doctor relationship, and the schedule of the doctor,
should be explored in future research.
Research should be conducted to provide further support for the third and fourth
hypotheses. To verify the efficacy of this headache center’s inpatient treatment program,
a control and comparison group should be used. A wait-list control group, as well as an
outpatient infusion treatment group, could be used in further research, comparing shortterm and long-term outcomes. Samples should be followed up every several months after
discharge to determine the length of treatment outcome maintenance. Research
comparing short-term and long-term outcomes of headache inpatient treatment with
alternative treatment options is essential in determining whether inpatient treatment is a
cost-efficient treatment option.
Limitations
While the alternative and exploratory hypotheses were not supported, null
hypotheses were not confirmed. Despite the plausible explanations discussed to account
for the absence of significant findings, the following limitations may have interfered with
the model’s ability to predict minimal improvement and/or a longer LOS. Of most
importance, the sample size was not large enough to detect significance. Another
potential confounding variable is that the sample population consisted of individuals
willing to participate. The characteristic of willingness to participate could be a factor
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that precluded the sample from being representative of the inpatient population with
headache, in addition to precluding experimental control of the study. Contrarily, Huber
and Henrich (2003) reported an association between patients with migraine and social
conformity, in which case a willingness to participate may be a characteristic that reflects
a representative sample of the inpatient population. Additionally, the sample was
homogenous, consisting primarily of Caucasian women. The homogenous sample,
despite being similar to the general headache population, may be a confounding variable
precluding experimental control of the study. The demographics of being a Caucasian
woman may have been a characteristic interfering with the models’ ability to predict LOS
and/or minimal improvement. In specific reference to the exploratory hypotheses, the
cases observed to be refractory during data review may not have occurred frequently
enough to warrant significance, or the sample size was not large enough to detect
significance.
Considering the limitations, another study with a larger, heterogeneous sample
would be required to confirm or disconfirm the models’ ability to predict LOS and
minimal improvement. Likewise, psychological factors may be lesser predictors,
secondary to medical variables (i.e., response to medication) or environmental variables.
Therefore, a larger than recommended sample size may be required to detect a
psychological factor’s significance amongst potentially stronger variables.
In reference to limitations related to the supported third and fourth alternative
hypotheses, there was no control group used for comparison against the inpatient
treatment. Therefore, the inpatient treatment may not have caused the significant
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improvement in headache severity and interference of daily functioning from headaches.
One cannot rule out that a sample under control-group conditions without treatment (in
which inpatients are excused from responsibilities and under the care of nursing staff)
would not demonstrate the same level of improvement as that of the treatment group.
Likewise, considering that this headache center’s inpatient treatment program is adjusted
to meet patients’ needs, there is variability in the treatment that each patient receives. The
variability of each inpatient’s treatment protocol could represent confounding variables.
This study obtained short-term outcomes; unfortunately, long-term outcomes of inpatient
treatment efficacy were not a focus of this study.
When replicating this study with an ample sample size, several considerations
should be made. Additional key personnel should be trained; data on inpatient
demographic characteristics should be collected prior to the start of data collection;
measures used should be brief, simple, and completed on-site; and participants should be
given time accommodations to complete measures. In order to accommodate for the
conditions of inpatient treatment, an ample key personnel staff is required. For example,
inpatients are often sleeping or unable to consent because of sedative effects of
medication. Key personnel should be available to check-in throughout the day in order to
obtain consenting participants. Likewise, key personnel are needed to collect outcome
data in order to prevent loss of participants as a result of uncompleted discharge
measures. Headache center staff have many responsibilities and should not be relied upon
for study protocol.
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Data regarding the inpatient sample demographics, particularly age, should be
collected prior to the beginning of data collection in order to determine whether the
hypotheses proposed are applicable to the characteristics of the sample population.
However, despite collecting demographic data on inpatients with headache prior to data
collection, determining the characteristics of inpatients willing to participate could still be
difficult.
The best practice is to use outcome measures that can be completed briefly in one
time period, rather than measures that have to be completed on a daily basis, over the
duration of the stay. Inpatients often did not complete the calendar in its entirety during
the duration of the stay. Participants required time accommodations for completion of the
MBMD. Inpatients were more willing to participate in the study if they had the option of
completing the MBMD on a day when their condition permitted more functionality.
Despite efforts to circulate the headache calendars to obtain the headache index score, at
the conclusion of data collection, the obtaining of calendars did not seem to improve
enough to permit their use as a reliable measure. If inpatients are required to bring from
home a calendar or any other kind of measure to be used as a baseline measure, they will
likely not bring the measure with them to the hospital. Baseline data are best collected at
admission.
Summary and Conclusions
The stages of creating a model that includes medical, environmental, and
psychological factors to predict negative treatment outcome for inpatients with headache
are still preliminary. The complex nature of the interaction of factors to predict treatment
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outcome is still largely unknown. Theories proposed regarding functional deficits and
coping skills should be explored in an effort to discover a psychological factor amenable
to treatment efforts that can, at least partly, predict a negative treatment outcome.
Neurologists and psychologists should collaborate their research efforts in order to
propose a model that includes medical, environmental, and psychological factors.
Particularly, neurologists and psychologists should examine the interactions among
medical, environmental, and psychological factors that may influence treatment outcome.
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